Development and characterization of in-vitro models for filaggrin associated skin diseases by Strüver, Kay
 DISSERTATION ZUR ERLANGUNG DES 
DOKTORGRADES 
DER FAKULTÄT FÜR CHEMIE UND PHARMAZIE 
DER LUDWIG – MAXIMILIANS - UNIVERSITÄT 
MÜNCHEN 
 
 
 
 
 
 
 
DEVELOPMENT AND CHARACTERIZATION OF IN-VITRO 
MODELS FOR FILAGGRIN ASSOCIATED SKIN DISEASES 
 
 
Kay Strüver 
aus 
Leipzig 
2018 
 
 ERKLÄRUNG 
Diese Dissertation wurde im Sinne von §7 der Promotionsordnung vom 28.  
November 2011 von Herrn Prof. Dr. Wolfgang Frieß betreut. 
 
 
 
 
EIDESSTATTLICHE VERSICHERUNG 
Diese Dissertation wurde eigenständig und ohne unerlaubte Hilfe erarbeitet. 
Berlin, den 24.10.2018 
 
 
Kay Strüver 
 
 
 
 
 
 
Dissertation eingereicht am: 04.09.2018 
1. Gutachter: Prof. Dr. Wolfgang Frieß 
2. Gutachter: Prof. Dr. Sarah Hedtrich 
Mündliche Prüfung am:  23.10.2018
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Für Karsten und Simone 
  
  
IV 
 
DANKSAGUNG 
Die vorliegende Doktorarbeit wurde in im Zeitraum von Juli 2012 bis April 2016 im 
Department Pharmazie an der Ludwig-Maximilians-Universität (LMU) in München, am 
Lehrstuhl für Pharmazeutische Technologie und Biopharmazie, angefertigt. Die 
Anfertigung der Arbeit erfolgte in Zusammenarbeit mit dem Institut für Pharmazie der 
Freien Universität Berlin, Fachbereich Pharmakologie und Toxikologie.  
Gleichermaßen möchte ich deshalb meinem Doktorvater und Betreuer Professor Dr. 
Wolfgang Frieß und meiner Betreuerin Professorin Dr. Sarah Hedtrich (geb. Küchler) 
für die Möglichkeit zum Durchführen dieser Arbeit, für die Mitarbeit in ihren 
Arbeitskreisen und die hervorragende wissenschaftliche Betreuung bedanken.  
Besonders für die Möglichkeit zum interdisziplinären Austausch während diverser 
Forschungsaufenthalte am Institut für Pharmazie der Freien Universität Berlin, bin ich 
ihnen sehr dankbar. Ohne diese Forschungsaufenthalte wäre die Anfertigung dieser 
Arbeit in dieser Form nicht möglich gewesen.  
Bedanken möchte ich ebenfalls bei Dr. Stefan Schreml und Dr. Robert Meier von der 
Universität Regensburg für die zusammen durchgeführten pH-Messungen an 
Hautmodellen. Genauso möchte ich mich bei Dominica für die sehr gute methodische 
Einarbeitung bedanken. 
Großer Dank gebührt auch meinen beiden Masterstudenten Frida und Ramona für die 
Unterstützung und den wissenschaftlichen Beitrag.    
Spezieller Dank geht an meine Laborpartnerin Madeleine für die wissenschaftliche 
Hilfestellung in der Anfangszeit und die Durchführung der UCA/PCA-Messungen, 
sowie an die beiden wunderbaren Laborpartner Verena und Christoph für die 
gemeinsame Zeit. 
An dieser Stelle möchte ich mich ganz ausdrücklich bei allen Kollegen der 
Arbeitsgruppen von Professor Frieß, Professor Winter, Professorin Merkel, Professorin 
Schäfer-Korting, Professor Weindl und Professorin Hedtrich für die exzellente 
Zusammenarbeit, die wissenschaftlichen Diskussionen und die Freizeitaktivitäten, 
welche weit über ein rein berufliches Verhältnis hinausgingen, bedanken.  
  
V 
 
Explizit bedanken muss und vor allem möchte ich mich dabei bei Kerstin und Laura für 
die moralische Unterstützung und Hilfe in den schwierigen Zeiten, sowie bei Leo, 
Stefan und Guy für die nicht aufzuwiegende Unterstützung während der letzten Jahre. 
Besonderer Dank gebührt natürlich Matze, welcher mich seit dem ersten Tag meiner 
akademischen Laufbahn begleitet hat und auch maßgeblich zu meiner Bewerbung in 
München beigetragen hat. Neben dem wissenschaftlichen Austausch möchte ich mich 
vor allem für seine Freundschaft bedanken.  
Zu guter Letzt möchte ich der absoluten Dankbarkeit gegenüber meiner Eltern 
Ausdruck verleihen. Vielen Dank für die Hilfe, Förderung und Liebe. 
  
  
VI 
 
TABLE OF CONTENT 
LIST OF TABLES _________________________________________________________________ IX 
LIST OF FIGURES ________________________________________________________________ X 
LIST OF ABBREVIATIONS ________________________________________________________ XII 
1 GENERAL INTRODUCTION ____________________________________________________ 1 
1.1 SKIN______________________________________________________________________ 2 
1.1.1 Structure and Function __________________________________________________ 2 
1.1.2 Skin Differentiation ______________________________________________________ 4 
1.2 FILAGGRIN-RELATED SKIN DISEASES ______________________________________________ 7 
1.2.1 Ichthyosis Vulgaris ______________________________________________________ 7 
1.2.2 Atopic Dermatitis _______________________________________________________ 7 
1.3 IN VITRO SKIN MODELS ________________________________________________________ 9 
1.3.1 General Overview ______________________________________________________ 9 
1.3.2 Bioreactors for Skin models ______________________________________________ 11 
1.4 REFERENCES ______________________________________________________________ 13 
2 AIM OF THE THESIS _________________________________________________________ 20 
3 FILAGGRIN DEFICIENCY LEADS TO IMPAIRED LIPID PROFILE AND ALTERED 
 ACIDIFICATION PATHWAYS IN A 3 D SKIN CONSTRUCT __________________________ 21 
3.1 ABSTRACT ________________________________________________________________ 22 
3.2 INTRODUCTION _____________________________________________________________ 23 
3.3 RESULTS _________________________________________________________________ 25 
3.3.1 Filaggrin Deficiency Leads to Impaired Lipid Profile and Altered  Acidification Pathways in 
a 3 D Skin Construct _________________________________________________________ 215 
3.3.2 FLG- constructs show significant upregulation of NHE-1 and sPLA2 IIA ___________ 25 
3.3.3 No differences of skin surface pH were found in FLG+ and FLG- ________________ 27 
3.3.4 FLG knock down leads to less ordered skin lipid barrier ________________________ 28 
3.3.5 FLG- constructs contain more FFA compared to normal constructs _______________ 29 
3.3.6 FLG- constructs display similar Cer profiles compared to FLG+ control ____________ 31 
3.3.7 Skin permeability is increased in FLG- for lipophilic agents _____________________ 32 
3.4 DISCUSSION _______________________________________________________________ 33 
3.5 MATERIALS AND METHODS ____________________________________________________ 37 
3.5.1 Preparation of Skin Constructs ___________________________________________ 37 
3.5.2 Fourier Transform Infrared (FTIR) Spectroscopy _____________________________ 37 
3.5.3 Isolation of SC Lipids ___________________________________________________ 38 
3.5.4 HPTLC Lipid Analysis __________________________________________________ 38 
3.5.5 Determination of FLG, sPLA2 and NHE-1 Expression __________________________ 38 
  
VII 
 
3.5.6 Skin surface pH measurements___________________________________________ 39 
3.5.7 Immunohistochemistry __________________________________________________ 39 
3.5.8 Skin permeability testing ________________________________________________ 40 
3.5.9 Statistical Analysis _____________________________________________________ 40 
3.6 ACKNOWLEDGEMENT ________________________________________________________ 41 
3.7 REFERENCES ______________________________________________________________ 42 
4 ESTABLISHMENT OF A DOUBLE KNOCKDOWN SKIN MODEL TO INVESTIGATE THE 
 IMPACT OF FILAGGRIN AND SODIUM/HYDROGEN ANTIPORTER 1 ON SKIN 
 ACIDIFICATION _____________________________________________________________ 47 
4.1 ABSTRACT ________________________________________________________________ 48 
4.2 INTRODUCTION _____________________________________________________________ 49 
4.3 METHODS _________________________________________________________________ 51 
4.3.1 Cell culture ___________________________________________________________ 51 
4.3.2 NHE-1 KD ___________________________________________________________ 51 
4.3.3 Construction of skin models ______________________________________________ 51 
4.3.4 RT-PCR _____________________________________________________________ 52 
4.3.5 Western blot __________________________________________________________ 53 
4.3.6 Hematoxylin-eosin (H&E) staining and immunofluorescence ____________________ 54 
4.3.7 Skin surface pH measurements___________________________________________ 54 
4.3.8 Statistical analysis _____________________________________________________ 54 
4.4 RESULTS _________________________________________________________________ 55 
4.4.1 Establishment of NHE-1 and filaggrin/NHE-1 double KD skin models _____________ 55 
4.4.2 Skin model characterization ______________________________________________ 58 
4.4.3 Skin surface pH measurements___________________________________________ 60 
4.4.4 sPLA2 expression ______________________________________________________ 60 
4.5 DISCUSSION _______________________________________________________________ 62 
4.6 ACKNOWLEDGEMENTS _______________________________________________________ 64 
4.7 REFERENCES ______________________________________________________________ 65 
5 DEVELOPMENT OF A PERFUSION PLATFORM FOR DYNAMIC CULTIVATION OF IN VITRO 
 SKIN MODELS ______________________________________________________________ 68 
5.1 ABSTRACT ________________________________________________________________ 69 
5.2 INTRODUCTION _____________________________________________________________ 70 
5.3 MATERIALS AND METHODS_____________________________________________________ 72 
5.3.1 Construction of perfusion platform _________________________________________ 72 
5.3.2 Cell culture ___________________________________________________________ 72 
5.3.3 Construction of skin models ______________________________________________ 72 
5.3.4 Hematoxylin-eosin (H&E) staining _________________________________________ 73 
5.3.5 Thickness measurements _______________________________________________ 73 
5.3.6 Real-time polymerase chain reaction (qPCR) ________________________________ 73 
  
VIII 
 
5.3.7 Western blot __________________________________________________________ 74 
5.3.8 Skin permeability testing ________________________________________________ 75 
5.3.9 Statistical analysis _____________________________________________________ 75 
5.4 RESULTS _________________________________________________________________ 76 
5.4.1 Set-up and establishment of a perfused bioreactor ____________________________ 76 
5.4.2 Histological analysis ___________________________________________________ 77 
5.4.3 Gene and protein expression of skin barrier and tight junction proteins following dynamic 
tissue cultivation _____________________________________________________________ 78 
5.4.4 Skin permeability studies ________________________________________________ 81 
5.5 DISCUSSION _______________________________________________________________ 82 
5.6 ACKNOWLEDGEMENTS _______________________________________________________ 84 
5.7 REFERENCES ______________________________________________________________ 85 
6 FINAL SUMMARY ___________________________________________________________ 89 
7 APPENDIX _________________________________________________________________ 92 
7.1 FILAGGRIN DEFICIENCY LEADS TO IMPAIRED LIPID PROFILE AND ALTERED ACIDIFICATION PATHWAYS 
IN A 3 D SKIN CONSTRUCT _________________________________________________________ 93 
7.1.1 Supplementary Methods ________________________________________________ 97 
7.1.2 References __________________________________________________________ 100 
7.2 PUBLICATIONS AND POSTER PRESENTATIONS ASSOCIATED WITH THE THESIS ______________ 101 
  
  
IX 
 
LIST OF TABLES 
Table 4-1 Primer sequences for PCR analysis __________________________________________ 53 
Table 5-1 Primer sequences for PCR. ________________________________________________ 74 
Table 5-2 Apparent permeability coefficient (Papp) of radioactively-labeled testosterone and caffeine 
(mean ± SD, n=3). ________________________________________________________________ 81 
Table 7-1 Ct values for NHE-1 and sPLA2-isoforms in the skin constructs (mean ± SEM, n= 8). ___ 93 
Table 7-2 Primer sequences for PCR. ________________________________________________ 93 
 
  
X 
 
LIST OF FIGURES 
Figure 1-1 Structure of the skin including antigen presenting cells. Taken from Engelke et al., 2015 
[4]. _____________________________________________________________________________ 2 
Figure 1-2 Epidermal differentiation. Taken from Sandilands et al., 2009 [17]. __________________ 5 
Figure 1-3 General correlation of in vitro model complexity and relevance for drug development (RHE 
– reconstructed human epidermis). Taken from Mathes et al., 2014 [47]. ______________________ 9 
Figure 3-1 Sodium/hydrogen antiporter (NHE-1) and secretory phospholipase A2 (sPLA2) IIA 
expression. _____________________________________________________________________ 26 
Figure 3-2 Skin surface pH of FLG+ (control) and FLG- (FLG knock down) constructs at day 4, 7 and 
14 of tissue cultivation and a histographical analysis of the spatial surface pH value distributions of the 
skin constructs using RGB-imaging luminescent 2D-imaging. ______________________________ 27 
Figure 3-3 Stratum corneum (SC) lipid chain order as indicated by the wavenumbers of the IR 
methylene symmetric (s) and asymmetric (as) stretching vibrations (panels a and c, respectively) and 
their corresponding bandwidths (panels b and d) of the hydrated SC. ________________________ 28 
Figure 3-4 The SC lipid content (panel a) and Cer profiles (panel b) in FLG+ and FLG- reconstructed 
skin grown for 14 d compared to human SC. ___________________________________________ 30 
Figure 3-5 Stratum corneum pH unifying concept. In FLG deficiency, NHE-1 and sPLA2 are 
upregulated to maintain the acidic pH needed for a variety of skin functions. Adapted and modified 
from Fluhr et al., 2001 [37]. _________________________________________________________ 36 
Figure 4-1 Relative mRNA expression of NHE-1 in normal human keratinocytes 48 h after (A) siRNA 
2 and (B) non-coding siRNA transfection quantified by RT-PCR, mean ± SEM, n = 3. (C) Protein 
expression of NHE-1 and β-actinin in normal human keratinocytes untreated and non-coding siRNA 
transfected. _____________________________________________________________________ 56 
Figure 4-2 (A) Relative mRNA expression of NHE-1 and (B) protein expression of NHE-1, FLG and β-
actin in normal human keratinocytes 48 h post transfection. (C) Relative mRNA expression of FLG 
(white) and NHE-1(grey bars) and (D) protein expression of NHE-1, FLG and β-actin in skin models. 
Relative mRNA expression quantified by RT-PCR; mean ± SEM, n = 3, *p ≤ 0.05, ***p ≤ 0.001. ___ 57 
Figure 4-3 Representative histological pictures of (A) normal, (B) FLG KD, (C) NHE-1 KD and (D) 
FLG/NHE-1 KD models after 14 days cultivation. Immunostaining against filaggrin (green) and NHE-1 
(red) in (E) normal, (F) FLG KD, (G) NHE-1 KD and (H) FLG/NHE-1 KD models. The cell nuclei were 
counterstained with DAPI (blue fluorescence), 20× magnification, scale bar = 50 µm. ___________ 59 
Figure 4-4 Representative skin surface pH of skin models at day 14 of tissue cultivation using RGB-
imaging luminescent 2D-imaging. ____________________________________________________ 60 
Figure 4-5 Relative mRNA expression of sPLA2 1B, 2F, V, X and IIA in NHE-1 and FLG/NHE-1 KD 
skin models quantified by RT-PCR; mean ± SEM, n = 4. __________________________________ 61 
Figure 5-1 (A) Scheme of the perfusion bioreactor. (B) Image of the perfusion platform equipped with 
cell culture insert, lid and tubing connectors. ___________________________________________ 76 
Figure 5-2 Representative histological pictures of (A) a skin model cultivated under static condition, 
(B) in the perfusion platform with a flow rate of 1.25 ml/h, (C) flow rate of 2.5 ml/h or (D) flow rate 7.5 
  
XI 
 
ml/h after 7 days of cultivation, SC: stratum corneum , VE: viable epidermis, D: dermis, 20x 
magnification, scale bar = 100 µm. ___________________________________________________ 77 
Figure 5-3 (A) Thickness of the stratum corneum after skin model cultivation of 7 days under static 
conditions or in the perfusion platform with flow rates of 1.25 ml/h, 2.5 l/h or 7.5 ml/h; (B) thickness of 
the stratum corneum (SC, light grey), viable epidermis (VE, dark grey) and dermis (D, white) after skin 
model cultivation of 7 days under static conditions or in the perfusion platform with flow rates of 1.25 
ml/h, 2.5 l/h or 7.5 ml/h. Mean ± SEM; n = 4; *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001. _______________ 78 
Figure 5-4 Impact of tissue cultivation in the perfusion platform on expression of (A) filaggrin, (B) 
involucrin, (C) claudin 1 and (D) occludin after 7 days of cultivation. Western blots and relative protein 
expression were semi-quantified by densitometry. Mean ± SEM, n = 4, *p ≤ 0.05. ______________ 79 
Figure 5-5 Relative mRNA expression of (A) filaggrin, (B) involucrin, (C) claudin 1 and (D) occludin in 
skin models cultivated for 7 days under static or dynamic conditions. Mean ± SEM, n = 4, *p ≤ 0.05. 80 
Figure 5-6 Cumulative amounts (mean ± SEM, n=3) of radioactively-labeled permeated (A) 
testosterone and (B) caffeine following topical application on skin models cultivated under static 
control or dynamic (1.25, 2.5, 7.5 ml/h) conditions. ______________________________________ 81 
Figure 7-1 FLG degradation products UCA (a) and PCA (b) concentrations after 14 days cultivation in 
FLG+, FLG- constructs and human samples determined using HPLC analysis. n=5, mean ± SEM, *p ≤ 
0.05 ___________________________________________________________________________ 94 
Figure 7-2 Time dependent expression of sPLA 1B, 2F, V and XIIA in FLG+ (grey bars) and FLG- 
(white bars). _____________________________________________________________________ 94 
Figure 7-3 Negative Control of NHE-1 immunostaining with (a) and without (b) DAPI staining of the 
nuclei. _________________________________________________________________________ 95 
Figure 7-4 FLG degradation products UCA (a) and PCA (b) concentrations after 4 and 7 days 
cultivation in FLG+ (striped bars) and FLG- constructs (blank bars) determined by HPLC analysis. 
n=2, mean ± SEM, *p ≤ 0.05 ________________________________________________________ 95 
Figure 7-5 Knock down efficiency in FLG- skin constructs at day 4, 7 and 14. n=4, mean ± SEM __ 96 
Figure 7-6 pH measurement controls. To ensure that our pH measurement method can detect pH 
differences in skin constructs when present, we removed the epidermis from the skin constructs after 
the pH measurement of the skin surface. As expected, we detected a neutral pH proving that the 
method we are using detects pH differences when present. _______________________________ 96 
 
  
XII 
 
LIST OF ABBREVIATIONS 
 
AD ATOPIC DERMATITIS 
AS α-HYDROXY SPHINGOSINE 
ATR ATTENUATED TOTAL REFLECTANCE 
BSA BOVINE SERUM ALBUMIN 
Cer CERAMIDE 
Chol CHOLISTEROL 
CholS CHOLESTEROL SULFATE 
EDC EPIDERMAL DIFFERENTIATION COMPLEX 
EOS CERAMIDE 1 
FFA FREE FATTY ACIDS 
FLG FILAGGRIN 
FTIR FOURIER TRANSFORM INFRARED 
GCer GLUCOCERAMIDE 
GCerase β-GLUCOCEREBROSIDASE 
GSph GLUCOSYLSPHINGOSINE 
H&E HEMATOXYLIN-EOSIN 
IL INTERLEUKIN 
IV ICHTHYOSIS VULGARIS 
KD KNOCK DOWN 
NHE-1 SODIUM HYDROGEN EXCHANGER 1 
NP PHYTOCERAMIDE 
NS NON-HYDROXY SPHINGOSINE 
PBS PHOSPHATE-BUFFERED SALINE 
PCA PYRROLIDON-5-CARBOXYLIC ACID 
PL PHOSPHOLIPID 
RHE RECONSTRUCTED HUMAN EPIDERMIS 
RT-PCR REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION 
SC STRATUM CORNEUM 
SM SPHINGOMYELIN 
SMase SPHINGOMYELINASE 
SPC SPHINGOSYLPHOSPHORYLCHOLIN 
sPLA SECRETED PHOSPHOLIPASES A 
TSLP THYMIC STROMAL LYMPHOPOIETIN 
UCA UROCANIC ACID 
 1 
 
1 GENERAL INTRODUCTION 
  
1. General Introduction 
 
 
2 
 
1.1 SKIN 
1.1.1 STRUCTURE AND FUNCTION 
Knowledge of the skin’s exact structure and function is crucial to understand skin 
diseases and to develop new therapeutic options. In general, skin has the extremely 
important function to provide a barrier between body and the environment. Skin 
protects us from environmental factors such as pathogens, chemicals, noxious 
physical and mechanical insults. It is necessary to regulate the body temperature and 
to prevent excessive loss of water. Furthermore, the skin is an enormous sensory 
organ with millions of different nerve endings that let our body feel touch, pain or heat 
[1,2]. To fulfill these function, the skin has a specific structure. In general, skin or cutis 
is divided into two main layers: the epidermis and dermis (Fig. 1). The underlying 
subcutis does not belong morphologically to the actual skin, although its fatty tissue 
supports the skin’s function [3].  
The epidermis – the outer stratum 
of the skin – is an avascular and 
multilayered epithelium. Adnexa 
like hairs, glands and nails belong 
to the epidermis. The thickness 
varies between 40 µm and 700 µm 
that may vary with mechanical 
exposure. For example, palms and 
soles have a pronounced 
epidermis with an additional layer 
– the stratum lucidum – and a 
depth of up to 700 µm while the 
skin of eyelids, on the other hand, 
exhibit the thinnest epidermis with 
a thickness of approximately 40 
µm  [5]. The epidermis consists to 
up to 95% of keratinocytes.  
Figure 1-1 Structure of the skin including antigen 
presenting cells. Taken from Engelke et al., 2015 [4]. 
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Other cells are melanocytes, Langerhans cells, Merkel cells and occasionally 
inflammatory cells [3,6]. The multilayered structure of the epidermis is based on the 
keratinocytes differentiation process of the keratinocytes. Starting from the outermost 
layer, the epidermis consists of the stratum corneum, stratum granulosum, stratum 
spinosum and stratum basale (see Figure 1) [1,3].  The stratum corneum (SC) is the 
main barrier of the skin.  
Fully differentiated, cornified, anucleated and flattened keratinocytes – also called 
corneocytes – are surrounded by a lipid multilayer, which in a healthy state, provide a 
very effective barrier. The intracellular lipids consist of 30% ceramides, 30% free fatty 
acids (FFA) plus cholesterol and its derivatives. Important to structural integrity are the 
long-chained ceramide esters [7]. Initially, Elias stated the brick and mortar model to 
describe the structure and function of the stratum corneum [8]. However, during the 
last two decades this model was revised. Four major structures contribute to the barrier 
function of the skin. First, cavities of corneocytes jam the corneocytes into each other. 
The second important structure are corneodesmosomes, transmembrane proteins that 
rivet corneocytes together.  The corneocytes with cavities and the corneodesmosome 
connections form an intercellular scaffold for the highly ordered lipid bilayer, the third 
structure. Finally, tight junctions attach the SC to the viable part of the epidermis [9]. 
The stratum lucidum only occurs on the sole of the foot and the palm of the hand. This 
additional layer has the function to reduce shear forces and friction on these very 
stressed body parts [3]. The stratum granulosum consists of two to four layers of 
keratinocytes that exhibit microscopically visible granules. These granules contain 
precursors of the lipid lamellae of the stratum corneum. The stratum spinosum contains 
the daughter cells of the basal layer, which show a polygonal form. Usually, the 
dimension of the stratum spinosum includes four to eight layers of keratinocytes. 
Langerhans cells are also present within the stratum granulosum and spinosum. The 
Langerhans cells have a dendritic shape and are part of the immune system. They 
absorb invading antigens and then present these to the immune system [1,3]. The 
regeneration of the epidermis occurs in the stratum basale. This layer is made of 
cylindric keratinocytes with ovoid nuclei. Besides the regeneration, the stratum basale 
is also involved in melanin production. In between the keratinocytes are dendritic 
melanocytes, which produce melanin and eumelanin. Melanin pigments serve as an 
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UV light filter and protect the body from UV radiation, converting 99.9% of the harmful 
radiation harmless heat. In addition, the basal layer also contains Merkel cells. This 
cell type is associated with unmyelinated nerve endings and is responsible for sensory 
perception [3]. 
The dermis is located underneath the stratum basale. The connection of the dermal-
epidermal junction is also called basement membrane. Keratinocytes from the basal 
layer are attached to this basement membrane by the anchoring filaments of 
hemidesmosomes that consist of integrins. The dermal side is connected to the 
basement membrane via collagen type VII filaments [10].   
The dermis is a connective tissue and consists mostly of fibroblasts surrounded by 
collagen, elastic fibers, hyaluronic acid and proteoglycans. The dermis can also be 
distinguished by distinct layers. The top lying papillary dermis is relatively thin and is 
composed of a loose and fine meshwork of fibers. The lower reticular dermis is much 
thicker and denser with fibers arranged in parallel to the skin surface. In contrast to the 
epidermis, the dermis is a vascularized tissue and supplies the epidermis with 
nutrients, water and partly oxygen via diffusion [3,11]. 
 
1.1.2 SKIN DIFFERENTIATION 
To achieve the described multilayer structure of the skin, the epidermis undergoes a 
complex process of proliferation and differentiation. The so called epidermal 
differentiation complex (EDC) plays a major role in this genetically driven process of 
skin differentiation [12–14]. The EDC is a region on the chromosome 1q21, which 
contains multiple genes responsible for skin differentiation. The precise regulation of 
this gene cassette is crucial for the proper maintenance of the skin barrier.  The over 
50 different EDC genes can be clustered in 3 families, the cornified envelope precursor 
family, the S100 protein family and the S100 fused type protein family [14,15].  
Stem cell keratinocytes, which are mitotically active, preserve the self-renewing 
capability of the skin. Following mitosis, their daughter cells detach from the stratum 
basale and start an ordered process of differentiation. The keratinocytes become 
flatter, larger and take on a polyhedral form.  Gene expression changes during their 
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migration through the epidermis. While in the stratum basale the proteins keratin 5, 14 
and 15 are present in keratinocytes, the transcription of keratins 1 and 10 is favourer 
in the spinous layer. Later, keratin 2 also accrues in the stratum spinosum [15]. In the 
stratum granulosum, the keratins built in the spinous layer remain present and the 
keratinocytes flatten further. Basophilic keratohyalin granules are microscopically 
visible in the cytoplasm. They contain keratin filaments, loricrin and the polyprotein 
profilaggrin (see Fig. 2) [16].  
 
 
Figure 1-2 Epidermal differentiation. Taken from Sandilands et al., 2009 [17]. 
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The proteins filaggrin and its precursor profilaggrin play a major role in skin 
differentiation. Profilaggrin consist of a S100-like calcium binding domain and a nuclear 
localization domain at the N-terminus, 10 to 12 similar filaggrin monomers in the middle 
of the polyprotein, and a specific C-terminal domain [18]. The calcium binding domain 
enables the regulation of terminal skin differentiation via calcium dependent events. 
The nuclear localization domain facilitates entry in to the nucleus and plays a role 
during enucleation. The domain at the C-terminus contributes to the processing of 
profilaggrin to filaggrin. The overall molecular weight of profilaggrin is over 400 kDa. 
The histidine rich protein filaggrin is released after dephosphorylation and degradation 
[18]. By assembling keratin filament aggregates, filaggrin, profilaggrin, involucrin, 
loricrin and further structural proteins and subsequently crosslinking these with 
disulfide bonds, the cornified envelope is created. In addition, skin lipids are 
accumulated within the lamellar bodies. In the final step, the disintegration of the nuclei, 
the cell membrane and further organelles takes place. The lamellar bodies release the 
lipids into intercellular space, forming an ordered lipid matrix. Together with the linked 
corneocytes, this forms the skin barrier [18,19].  
Besides the cornified envelope, filaggrin further contributes to the skin’s barrier 
function. In the upper SC, filaggrin is degraded to release amino acids; mostly histidine. 
The amino acids are part of the skin’s natural moisturizing factor. The released 
histamine is partly metabolized to trans urocanic acid (UCA) and pyrolidone-5-
carboxylic acid (PCA). The cis-enantiomer of UCA has an immunomodulatory effect in 
keratinocytes and leucocytes, and UCA and PCA contribute to UV photoprotection 
[18]. In addition, the participation of UCA and PCA to skin acidification is discussed 
[20–23] and detailed investigations are part of this thesis. The described functions of 
profilaggrin and filaggrin have a strong influence on a sound skin function and barrier. 
Notably reduced amounts of filaggrin are linked to skin disorders and diseases.   
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1.2 FILAGGRIN-RELATED SKIN DISEASES 
1.2.1 ICHTHYOSIS VULGARIS 
Ichthyosis vulgaris (IV), also known as autosomal dominant ichthyosis, is the most 
common form of ichthyosis. Phenotypic characteristics of IV are palmar hyper-linearity, 
lichen pilaris and fine scales over the lower abdomen, arms, and legs. IV is a single 
gene disorder and caused by filaggrin null mutations [24,25]. More than 40 truncating 
FLG mutations are described in literature, including Asian- and European-specific 
mutations. The most common loss-of-function FLG mutations in Europe are R501X 
and 2282del4 [26]. Heterozygous mutation of R501X or 2282del4 leads to a mild form 
of IV, while homozygous mutations lead to severe forms of IV. Heterozygous 
R501X/2282del4 mutations are also known and lead to severe cases of IV [27]. 
As the polyprotein profilaggrin is the major component of those granules found in the 
granular layer of the epidermis, the histological absence of this layer in severe forms 
of profilaggrin null IV is not surprising [24,25,28]. Furthermore, the lack of profilaggrin 
and coherent filaggrin leads to a disordered lamellar bilayer in the SC that in turn 
causes the impaired barrier function often found in patients with IV [27]. 
 
1.2.2 ATOPIC DERMATITIS 
Atopic dermatitis (AD) or atopic eczema is a highly pruritic, chronic inflammatory skin 
disorder and a very common dermatological disease. Its prevalence is up to 20 % in 
children [29] and up to 7 % in adults [30] with particular prevalence in in industrialized 
countries. The onset of AD occurs earlier than at the age of 5 in more than 70% of all 
cases, and the intensity of the disease symptoms often diminish with age, frequently 
vanishing by adolescence. Furthermore, 40% of patients with AD exhibit systemic 
atopic comorbidities such as allergic rhinitis, asthma or IgE related food allergies 
[26,31]. AD varies from mild acute forms to severe chronic forms with high impact on 
quality of life. This occurs owing to the multifactorial disease pattern of AD in which 
genetic, environmental and immunological factors all play prominent roles [32,33]. FLG 
null mutation is the major predisposing factor for AD but, notably, not all patients with 
AD carry mutations in the FLG gene. 
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Despite the high and still increasing prevalence of AD, its pathogenesis remains poorly 
understood. One decade ago, there was a change in basic assumptions. Whereas 
previously AD was thought to be an immune-mediated disorder, the fact that skin 
barrier deficiencies play a prominent role required re-evaluation of the disease [34]. 
The immunological constituent, associated with elevated levels of IgE, caused mainly 
by the T-cell cytokines IL-4 and IL-13, was well established [35,36]. This progression 
starts with elevated levels of Th17 associated cytokines followed by increased levels 
of Th2 cytokine family members like the aforementioned IL-4 and IL-13. The 
contribution of increased thymic stromal lymphopoietin (TSLP) levels was also 
recognized [37]. Since then, barrier function impairment has come into focus as a 
primary cause for AD [34,38,39]. Nevertheless, TSLP and further cytokines like IL-33 
and IL-25 strongly contribute to the atopic diseases and drive the progression from AD 
to asthma [40]. In 2006, Palmer and colleagues described loss-of-function variants of 
FLG such as caused by the null mutations R501X and 2282del4, as the main 
predisposing factors for AD, with up to 40% of all patient with AD having loss-of-
function variants of FLG [25,41]. The impaired barrier function of the skin leads to 
enhanced trans-epidermal water loss and the entry of allergens and irritants through 
the epidermis. Those allergens and irritants in turn trigger the Th2 and Th22 immune 
response. The following inflammation of the skin decreases the barrier function even 
further.  
Besides the FLG null mutations, further genetic factors can contribute to AD. 
Polymorphisms of desmosomes or, for example, mutations of the serine peptidase 
inhibitor Kazal type 5 (SPINK5) can also lead to an impaired skin barrier. Relevant 
single nucleotide polymorphisms in the Th2 cytokine family can also lead to higher 
expression rates of IL-4 and IL-13, which trigger the immune-mediated part of the 
disease [42,43]. In addition, IL-4 and IL-13 also themselves reduce the expression rate 
of FLG and helps explains the reduce FLG amounts in all AD patients, independent 
from the genomic aberrations [44,45]. 
The lack of filaggrin and its impact on skin disease like IV and AD were a major focus 
of this thesis. For this purpose, reconstructed skin models, including new skin disease 
models, were to be investigated and developed.  
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1.3 IN VITRO SKIN MODELS 
1.3.1 GENERAL OVERVIEW 
Various in vitro test systems are available to investigate skin physiology, skin diseases 
and drug application routes through the skin [46]. The general complexity of in vitro 
skin models increases with higher relevance for research and drug development 
(Figure 3) [47]. For example, monolayer cell culture of keratinocytes is used for basic 
drug substance response investigations and comparison of cytokine profiles from 
healthy and unsound donors [48].  More complex formats like co-culturing of 
keratinocytes and fibroblast enable insights into cellular crosstalk and improves the 
significance of those models. Two decades ago, Sato et. al already showed the 
benefits of keratinocyte-fibroblast coculturing [49].   Nevertheless, 2D cell culture 
technique has obvious limitations, e.g. investigation of the barrier function or 
permeability of active compounds or allergens [50].  
 
Figure 1-3 General correlation of in vitro model complexity and relevance for drug 
development (RHE – reconstructed human epidermis). Taken from Mathes et al., 2014 [47]. 
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The more complex reconstructed human epidermis (RHE) models and full thickness 
skin models mimic the physiology of human skin adequately and are partly validated 
for skin irritation, corrosions and phototoxicity tests [51–54]. RHE models were one of 
the earliest skin models based on tissue engineering. The development derived from 
skin grafts to treat chronic or burn wounds.  As the name already indicates, these 
models consist of differentiated keratinocytes. To generate these models, it is possible 
to use primary keratinocytes as well as keratinocyte cell lines. Usually primary cells or 
immortalized cells are cultivated and proliferated with standard cell culture procedures 
[55]. The cultivated cells are then transferred to special inserts. After overnight 
incubation, these inserts are lifted to an air-liquid interface and the medium is changed 
from a growing medium to a differentiation medium. Caused by the medium and the 
air contact, keratinocytes start to differentiate. After seven to 14 days, all layers of the 
epidermis are visible in a microscope section.  
RHE models are useful for different applications, including drug permeation studies 
and investigations on the impact of genetic modifications on the barrier function [56]. 
Pendaries et al. used mRNA interference in RHE models to investigated the influence 
of filaggrin on skin differentiation to further conclude about the pathophysiology of AD 
[57]. Furthermore, Danso et al. used cytokine treated RHE models to mimic AD and 
an impaired skin barrier [58]. Possible application for those models are screening tests 
for new AD treatments.  
Full-thickness models further contains a dermis equivalent with incorporated 
fibroblasts. These advanced models offer the benefit of fibroblasts attachment together 
with surrounding polymers as well as growing and differentiation of the keratinocytes 
[59,60]. One further advantage is the possibility to include additional cells in the skin 
model. For example, the incorporation of immune cells can help to mimic the 
multifactorial disease pattern of AD. Engelhart et al. included activated T-cells in 
reconstructed full-thickness skin models and could reproduce atopic hallmarks in 
reconstructed skin [61]. Wallmeyer et al. even combined genetically modified filaggrin 
deficient models with the exposure of activated T-cell to gain new insights into AD, like 
the roll of TSLP [62]. 
Nevertheless, reconstructed skin models exhibit several limitations and disadvantages.  
In general, the permeability of reconstructed skin models is higher, and their 
1. General Introduction 
 
 
11 
 
mechanical resistance lower as compared to human or animal skin [63]. This can be 
explained by an inferior lipid organization, altered ceramide profiles and lower 
expression of skin differentiation markers. Furthermore, the characteristics are strongly 
dependent on the culture conditions of the generated models. In contrast to human or 
animal tissue, reconstructed skin lacks mechanical stimuli associated with daily 
activities of living. Bioreactors for skin models are a promising tool to overcome those 
obstacles.  
 
1.3.2 BIOREACTORS FOR SKIN MODELS 
Bioreactors are a promising tool to provide a complex growing environment to further 
improve the concept of tissue engineering [64]. The term bioreactor comprises multiple 
laboratory tissue-engineering devices. They are designed to introduce an active and 
controllable growing environment to improve the tissue properties [65].  In general, 
bioreactors can help to reduce manual tasks, to speed up cell expansion, decrease 
costs and standardize growing conditions. For example, bioreactors introduce a 
laminar flow of medium, diffusion limitations can be reduced, and the mass transport 
of nutrients is optimized. In addition, mechanical forces, like stretching or shear stress, 
increase cell density and tissue robustness. This is caused by modulation of the cell 
physiology and by increasing the biosynthetic activity of cells [66]. For example, 
osteoblasts exhibit higher amounts of specific cross-linked proteins like actin or filamin 
after exposure to fluid shear stress [67]. The exact physiological process by applying 
fluid shear stress is not completely understood.  
The pioneers of bioreactors for skin are found in anaplasty. To treat ulcers or burn 
wounds, plastic surgeons often use split-thickness skin grafts. However, the expansion 
of skin comes along with the lack of elasticity, contraction, and scarring. To overcome 
those obstacles, bioreactors were used to improve the growing conditions and finally 
the quality of skin grafts [68,69].  
Applications for bioreactors in tissue engineering of skin constructs are cell expansion 
or the generation and maturation of the construct [63]. Today, the most common 
bioreactors for the maturation phase are designed like flow-through platforms. While 
the skin construct can grow at an air-liquid interphase, a medium flow is applied below 
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the construct [68,70]. Often these flow-through platforms are connected to peristaltic 
pumps and the whole assembly is stored in a common cell culture incubator to maintain 
general growing conditions like temperature, humidity, and carbon dioxide 
concentration.  
The combination of tissue engineering, genetic modifications and bioreactors enables 
the development of highly complex skin disease models, which more closely resemble 
the characteristics of in-vivo models. Step by step it is possible to gain new insights in 
skin disease and to avoid animal models, which come with ethical concerns.  
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2 AIM OF THE THESIS 
The aim of the present thesis was to gain detailed insights into the role of FLG in FLG 
related skin disease like AD. Based on the knowledge about the lack of FLG in IV and 
AD, the focus of this thesis was to characterize and further develop in vitro models for 
FLG related skin disease. Significant disease models are crucial to improve the 
understanding of the pathophysiology and to establish new therapeutic strategies. 
First, the overall impact of FLG mutations in AD was to be investigated, including an 
intensive characterization of the previously for this purpose established FLG knock-
down models. Skin surface pH, gene expression of relevant proteins, skin lipid profiles 
and the barrier function were to be analyzed in detail comparing sound and disease 
models. The gained knowledge should help to distinguish between barrier related and 
immune related pathogenic factors in AD. 
Based on the results, the interplay between the different contributors to the acidic 
surface pH of the skin was to be further analyzed. Beside the FLG knock down model, 
the goal was the establishment of a NHE-1 knock down and a FLG/NHE-1 double 
knock down model and to carry out a comparison of the surface pH between all these 
models. 
Developing the reconstructed in vitro skin models demonstrated the need for further 
improvement. Amongst other differences, the models exhibit less mechanical 
resistance and a weaker barrier function compared to in-vivo skin. Therefore, the goal 
for the last part was to develop a perfusion bioreactor for skin cultivation and to carry 
out a detailed characterization of the obtained dynamic models regarding barrier 
function and expression of relevant skin differentiation factors. 
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3 FILAGGRIN DEFICIENCY LEADS TO IMPAIRED LIPID PROFILE AND 
ALTERED ACIDIFICATION PATHWAYS IN A 3 D SKIN CONSTRUCT 
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3.1 ABSTRACT 
Mutations in the FLG gene are strongly associated with common dermatological 
disorders such as AD. However, the exact underlying pathomechanism is still 
ambiguous. Here, we investigated the impact of FLG on skin lipid composition, 
organization and skin acidification using a FLG knock down (FLG-) skin construct. 
Initially, NHE-1 activity was sufficient to maintain the acidic pH (5.5) of the 
reconstructed skin. At day 7, the FLG degradation products UCA and PCA were 
significantly decreased in the FLG- but the skin surface pH was still physiological due 
to an upregulation of NHE-1. At day 14, secretory phospholipase A2 (sPLA2) IIA, which 
is converting phospholipids to fatty acids, was significantly more activated in the FLG- 
than in FLG+. Although NHE-1 and sPLA2 were able to compensate the FLG 
deficiency, maintain the skin surface pH and ensured ceramide processing (no 
differences detected), an accumulation of FFA (twofold increase) led to less ordered 
intercellular lipid lamellae and higher permeability of the FLG- constructs. The interplay 
of the UCA/PCA and the sPLA2/NHE-1 acidification pathways of the skin and the 
impact of FLG insufficiency on skin lipid composition and organization in reconstructed 
skin, to our knowledge previously unreported, are described.  
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3.2 INTRODUCTION 
FLG loss-of-function mutations contribute to several dermatological disorders such as 
IV and AD [1,2]. Mutations in the FLG gene are the most-widely occurring genetic risk 
factors for AD known to date and have been identified in up to 20-40 % of the patients 
[2–4]. Although FLG mutations are the most common mutations in these skin 
disorders, still the overall impact on the pathogenesis is not understood in full.  
FLG is crucial for the adequate development of the epidermal structure and barrier 
function [1]. It is ultimately degraded to its component amino acids including histidine. 
These amino acids are highly hygroscopic and are the major components of the 
“natural moisturizing factor” which is crucial for epidermal hydration and barrier function 
[5]. Histidine is of particular importance as it is eventually metabolized to UCA and PCA 
which contribute to the acidification of the SC via the “histidine-to-UCA/PCA pathway” 
[6,7]. Furthermore, due to the importance of the acidic pH for the formation of the ‘acidic 
mantle’ other pathways contribute to its formation [8]. This includes the NHE-1 and the 
“phospholipid (PL)-to-FFA pathway” via secreted phospholipases (sPLA2) [6,9]. 
However, until now the interplay and impact of the single pathways on the formation of 
the acidic skin surface pH remains unclear. The acidic mantle is a prerequisite for the 
formation of ceramides (Cer), i.e., the most important lipid class in the SC intercellular 
lipid matrix, and, thus, directly influences the skin barrier development: In the SC the 
ß-glucocerebrosidase (GCerase) and acid sphingomyelinase (SMase) metabolize 
glycosylceramides (GCer) and sphingomyelin (SM) to Cer. Both enzymes require an 
acidic environment of pH ≤ 5.5 for their optimal activity [10]. Thus, a decreased 
production of UCA/PCA due to a lack of FLG could result in an increase of SC pH and, 
consequently, to a decreased Cer content. This assumption was underlined by the 
reduced Cer levels found in AD patients [11–15]. 
We have previously described a FLG- skin construct which exhibits disturbed 
epidermal maturation and differentiation, increased susceptibility to irritants and altered 
drug absorption [16]. In this study, we investigated how the lack of FLG influences the 
composition and organization of the SC lipids generated in FLG- constructs in 
comparison to normal skin constructs and isolated human SC and how skin absorption 
is influenced. Additionally, we determined the amount of UCA/PCA, the expression of 
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various sPLA2 subtypes and of the sodium-hydrogen antiporter NHE-1, sPLA2 activity 
and the skin surface pH in a time dependent manner to gain deeper insights in the 
mechanisms of skin acidification.  
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3.3 RESULTS 
3.3.1 FLG- CONSTRUCTS CONTAIN SIGNIFICANTLY LESS UCA AND PCA 
COMPARED TO HEALTHY SKIN MODELS  
The knock down efficiency of our FLG- constructs was 75.7 ± 2.83 % (n = 10, Figure 
S5). As expected, FLG knock down decreased the levels of the histidine degradation 
products PCA (FLG+ 0.45 ± 0.05 mmol/g protein; FLG- 0.22 ± 0.04 mmol/g protein) 
and UCA (FLG+ 0.018 ± 0.003 mmol/g protein; FLG- 0.011 ± 0.002 mmol/g protein) at 
day 14 (Supplementary Figure S1). Similar differences were detected at day 7, but not 
at day 4 (Figure S4). In comparison to human skin (UCA 0.210 ± 0.045 mmol/g protein; 
PCA 2.65 ± 0.42 mmol/g protein), PCA and UCA levels were reduced.  
 
3.3.2 FLG- CONSTRUCTS SHOW SIGNIFICANT UPREGULATION OF NHE-1 AND 
SPLA2 IIA  
We found a significant upregulation of NHE-1 in the FLG- constructs compared to 
FLG+ starting at day 7. No significant differences were seen at day 4 on the mRNA 
(Figure 1 a) and protein level. sPLA2 IIA was only found at day 14 in the constructs, its 
relative expression being significantly higher in the FLG- construct (Figure 1 a). The 
upregulation of sPLA2 IIA and NHE-1 was further confirmed on the protein level (Figure 
1 b). sPLA2 -IB, -IIF, -V and -XIIA were detected, too, some of them are only expressed 
at day 14 and without statistically significant differences between FLG+ and FLG-, 
respectively (Supplementary Figure S2). Because of the relatively small difference in 
sPLA2 IIA on mRNA level, we also checked for the activity of the enzyme detecting an 
about 55 % increased sPLA2 activity in FLG- (36.28 ± 10.70 units/ml) compared to 
FLG+ (23.38 ± 7.70 units/ml).  
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Figure 3-1 Sodium/hydrogen antiporter (NHE-1) and secretory phospholipase A2 (sPLA2) IIA 
expression. 
a Relative mRNA expression of NHE-1 and sPLA2 IIA in FLG+ (striped bars) and FLG- (white 
bars) constructs at days 4, 7 and 14 quantified using RT-PCR. Mean ± SEM, n = 10, * p ≤ 0.05 
 b Protein expression in FLG+ and FLG- constructs; the expression of NHE-1 and sPLA2 IIA 
at day 14 is clearly increased (green fluorescence). The nuclei were stained with DAPI (blue 
fluorescence) (bar = 100µm). 
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3.3.3 NO DIFFERENCES OF SKIN SURFACE PH WERE FOUND IN FLG+ AND FLG-  
Interestingly, we measured a physiological skin surface around pH 5.5 from day 4 
through 14 of tissue cultivation. No differences were detected between the FLG+ and 
FLG- constructs. The respective absolute values are given in Figure 2.  
 
Figure 3-2 Skin surface pH of FLG+ (control) and FLG- (FLG knock down) constructs at day 
4, 7 and 14 of tissue cultivation and a histographical analysis of the spatial surface pH value 
distributions of the skin constructs using RGB-imaging luminescent 2D-imaging. 
Regions of interest are marked with circles, and the respective mean pH values ± SD are given. 
No differences were observed between FLG+ and FLG- at day 4 (n=2), day 7 (n=4) and day 
14 (n=4), respectively.  
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3.3.4 FLG KNOCK DOWN LEADS TO LESS ORDERED SKIN LIPID BARRIER 
 
Figure 3-3 Stratum corneum (SC) lipid chain order as indicated by the wavenumbers of the IR 
methylene symmetric (s) and asymmetric (as) stretching vibrations (panels a and c, 
respectively) and their corresponding bandwidths (panels b and d) of the hydrated SC. 
Samples from FLG+ and FLG- skin models grown for 7 and 14 d compared to isolated human 
SC. The hydrated SC samples were examined by ATR-FTIR spectroscopy by co-addition of 
256 scans at 4 cm-1 resolution at 23 °C. Mean ± SEM, n = 8, * indicates statistically significant 
differences compared to human SC or as indicated at p ≤ 0.05. 
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The lipid chain order in the SC sheets from normal and FLG- constructs was examined 
by ATR-FTIR spectroscopy and compared to hydrated human SC. Cultivated for 7 d, 
the constructs displayed more disordered lipid chains than the human SC as indicated 
by the shift of both the methylene symmetric and asymmetric stretching vibrations 
towards slightly higher wavenumbers (over 2851 cm-1 and ~2921 cm-1, respectively, 
compared to 2850 cm-1 and 2918 cm-1 in human SC) and significant broadening of both 
bands due to incorporation of more gauche conformers into the lipid chains [17]  
(Figure 3). No differences were found between FLG+ and FLG- cultures at day 7.  
In contrast, cultivation for 14 d led to significant differences between the lipid chain 
conformations of the constructs. While the normal cultures showed a trend towards 
improving the lipid chain order reflected by lower wavenumbers of methylene 
stretching bands and decreased bandwidths, the opposite was found for FLG-. The 
methylene symmetric stretching in the FLG- construct reached ~2852 cm-1, indicating 
a higher proportion of a liquid ordered phase [18] where the lipid chains are still more 
ordered than in the fluid phase but display greater lateral and rotational freedom. This 
is consistent with the character of the methylene scissoring mode, which appeared as 
a single band at around 1466 cm-1 indicating a laterally disordered phase. The relative 
amounts of lipids, determined as the corrected area under the C-H stretching vibration, 
and also the lipid/protein ratios, were similar in both models.  
 
3.3.5 FLG- CONSTRUCTS CONTAIN MORE FFA COMPARED TO NORMAL 
CONSTRUCTS 
The total lipid content was very similar in both FLG- and FLG+ constructs 
(approximately 100 μg/mg of dry SC). No differences were found between the 7 d 
models consistently with the FTIR results and [19]. After 14 d cultivation of FLG+ 
constructs, the amounts of the major barrier lipids FFA (11.3 ± 2.1 μg), Chol (12.5 ± 
2.1 μg), Cer (21.1 ± 3.7 μg) and CholS (1.3 ± 0.5 μg) per mg of SC (Figure 4 a) 
correspond to a roughly equimolar mixture of FFA, Chol, and Cer, which is in 
agreement with previous studies [20]. Yet, the amount of these barrier lipids was 
significantly lower in either construct than in human SC (Figure 4 a). In the skin models, 
significant amounts of more polar lipid precursors including SM, GCer and PL were 
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detected explaining the lower lipid chain order of the in vitro constructs compared to 
human SC.  
 
Figure 3-4 The SC lipid content (panel a) and Cer profiles (panel b) in FLG+ and FLG- 
reconstructed skin grown for 14 d compared to human SC. 
The analyses were performed on silica gel 60 HPTLC plates and quantitated by densitometry 
after dipping in 7.5% CuSO4, 8% H3PO4, and 10% MeOH in water for 10 s and heating at 160 
°C for 30 min. Cer, FFA, and Chol were separated using chloroform/methanol/acetic acid 
190:9:1.5 (v/v/v) twice to the top of the plate. The other lipids were separated using 
chloroform/methanol/acetic acid/water 65:25:6:3 by volume. Mean ± SEM, n > 17, * indicates 
statistically significant differences compared to human SC at p ˂ 0.05, + indicates statistically 
significant differences between FLG+ and FLG- skin models at p ˂ 0.05. 
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In FLG- cultivated for 14 d, all these lipid classes were found, too. The only significant 
difference between FLG- and FLG+ was an almost twofold increase in FFA (21.9 ± 3.6 
μg/mg) accompanied by slightly less PL (22.3 ± 5.8 μg/mg) (Figure 4 a), suggesting an 
increased PL processing into FFA by sPLA2. Importantly, neither glucosylsphingosine 
(GSph) nor sphingosylphosphorylcholine (SPC), i.e. the degradation products of SM 
and GCer found previously in AD [21], was detected. 
 
3.3.6 FLG- CONSTRUCTS DISPLAY SIMILAR CER PROFILES COMPARED TO FLG+ 
CONTROL 
The overall Cer profiles were similar in both in vitro skin models (Figure 4 b). The major 
Cer species in the skin constructs were Cer NS and NP (28.8 ± 0.3 % and 41.1 ± 
2.1 %), which is similar to native human SC, where these Cer species accounted for 
21.3 ± 3.6 % and 35.3 ± 4.2 %, respectively. The band below Cer NS was assigned to 
its shorter analog (8.7 ± 1.3 %, labeled as Cer NS2). Such a subfraction of Cer NS was 
not present in human SC but was detected in reconstructed epidermal models 
previously [22,23]. The more polar Cer bands attributed to hydroxylated Cer AS/NH 
and Cer AP/AH, constituted 14.4 ± 2.3 % and 2.7 ± 0.6 % of the Cer mass compared 
to 17.7 ± 2.1 % and 16.2 ± 2.7 % in human SC, respectively. The AcylCer species, i.e., 
EO-type Cer, were found in some but not all lipid models. The mean levels were around 
1% for either EOS or EOH, which is lower than in human SC, where they comprised 4 
to 5 %. Cer EOP concentrations were below the detection limit. The highest amounts 
of Cer EOS and EOH detected were 4.9 % and 3.4 % with no significant differences 
between the skin constructs.  
Notably, the percentages of all sphingosine-based Cer (i.e., CerEOS, NS, NS2, and 
AS) were slightly lower in the FLG- constructs but without statistical significance.  
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3.3.7 SKIN PERMEABILITY IS INCREASED IN FLG- FOR LIPOPHILIC AGENTS 
We also determined the permeability of the skin constructs. Testosterone (logP = 3.47) 
served as lipophilic, caffeine (logP = -0.08) as a hydrophilic model drug. At day 7, 
neither for testosterone nor caffeine significant differences in skin permeability were 
found in FLG+ and FLG-. For testosterone, mean apparent permeability coefficients 
(Papp) ± SEM were 5.01 ± 0.37 x 10-6 (FLG+) and 5.13 ± 0.31 x 10-6 cm/s (FLG-). For 
caffeine, Papp values were 9.33 ± 0.51 x 10-6 for FLG+ and 10.03 ± 0.93 x10- 6 cm/s for 
FLG-. At day 14, significantly higher skin permeability was found for testosterone in 
FLG- in our previous work, while no differences were detected for caffeine [16]. 
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3.4 DISCUSSION 
The association of FLG mutations with ichthyosis vulgaris and AD is well established 
[1]. However, the exact mechanisms leading from genetic defects to clinical 
manifestation and the overall impact of these mutations are still ambiguous [1]. To 
investigate the impact of FLG on the skin barrier formation we developed an in vitro 
FLG deficient skin construct by knocking down its expression in primary, human 
keratinocytes using siRNA [16]. In this study, we elucidated the influence of FLG on 
the skin lipid formation and composition and the acidification mechanism in FLG 
deficient constructs in a time dependent manner. The advantage of in vitro FLG knock 
down constructs is that we are able to investigate the influence of FLG alone without 
other possibly contributing factors.   
In terms of skin lipid organization, we found less ordered intercellular lipid lamellae in 
FLG- constructs compared to the normal constructs at day 14 indicating a decreased 
viscosity and higher degree of freedom of mobility of the lipid chains. A similar 
decrease in lipid chain order was found in non-lesional SC from patients with AD and 
psoriasis [24]. This disorder was accompanied by a significantly higher permeability for 
lipophilic drugs in FLG- skin construct at day 14 [16], which is in agreement with [25]. 
These results correspond well with the observed changes in sPLA activity 
(upregulation at day 14), fatty acid level (increase at day 14) and skin lipid order 
(decreased at day 14) in FLG-.  In contrast, no differences in permeability were found 
at day 7. 
When considering the lipid chain packing, electron diffraction showed a higher 
proportion of hexagonal compared to orthorhombic lateral chain packing in AD patients 
[26]. However, we were unable to confirm this finding as our in vitro constructs 
generally did not form the orthorhombic lipid lattice. This is well in accordance with 
findings from other skin constructs  [27].  
First, we assumed that the changes in the lipid chain order must be related to a 
decrease in Cer levels in the FLG- constructs. Such a lack of Cer was described 
repeatedly in AD patients [11,12,14,28]. The lack of FLG and, thus, the impairment of 
the UCA/PCA acidification pathway may affect the activity of the Cer-generating 
enzymes GCerase and SMase that need an acidic pH [6]. On the other hand, 
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comparable Cer levels in AD and healthy skin were also found in vivo [29]. Although 
our lipid analyses showed lower levels of Cer in the FLG- constructs, this was neither 
statistically significant nor consistently found in the individual tissues. Therefore, there 
must be additional mechanism independent of FLG mutations leading to Cer 
deficiency. This is in agreement with recent reports [30,31]. The ability to generate Cer 
from their precursors can be explained by increased sPLA2 and/or NHE-1 activity which 
acidify the SC in the absence of UCA/PCA and, thus, ensure the activity of GCerase 
and SMase [8]. 
The Cer profiles were similar in both constructs; we only found a slight decrease in 
total sphingosine-based Cer in FLG- compared to FLG+. This seems to be 
contradictory to the lower abundances in Cer NP and total Cer EO in AD patients [31]. 
However, in that study, patients with the most prevalent FLG mutations were excluded 
suggesting that those changes were FLG independent. Unfortunately, only some of 
our constructs contained detectable amounts of the EO-type Cer; thus, we could not 
study whether FLG knock down contributes to the decrease of these extremely long 
acylCer found previously in AD [15]. Notably, neither GCer nor SPC were detected in 
the skin constructs. These lysolipids are formed from GCer and SM, respectively, by 
the action of GCer-SM-deacylase, which is highly expressed in the skin of AD patients. 
The breakdown of these Cer precursors leads to Cer deficiency and barrier disruption 
[21,32]. Our data suggest that there is no link between FLG and GCer-SM-deacylase 
in AD, both can independently contribute to skin lipid barrier abnormalities. 
The most striking feature in the SC lipid profiles of our skin constructs was the almost 
twofold increase of the FFA fraction in FLG- compared to FLG+ at day 14 strongly 
suggesting an involvement of sPLA2 as an alternative acidification pathway. Indeed, at 
day 14 we observed a significant increase of sPLA2 IIA in FLG- constructs and an 
about 55 % increased sPLA2 activity explaining the high amounts of FFA. This is in line 
with previous in vivo findings: twice higher FFA levels were found in atopic epidermis 
(1.30 +/- 0.74 mg/g wet weight) compared to healthy epidermis (0.61 +/- 0.14 mg/g)  
[33]. Furthermore, Tarroux et al., found significantly increased sPLA activity in atopic 
skin and a decrease in activity upon treatment [34]. The increased production of FFA 
due to sPLA2 IIA upregulation not only disturbs the lipid ratio and lipid order in the skin 
barrier but also directly contributes to inflammatory processes [9].  
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Because these changes were detected only at day 14, we further investigated the time 
course of the pH values of the skin constructs. Interestingly, we found a physiological 
pH of about 5.5 from day 4 through 14 of tissue cultivation in both constructs 
suggesting that other mechanisms than FLG maintain the SC acidity in the absence of 
FLG. Initially, at day 4, the basal activity of NHE-1 is fully sufficient to maintain the 
acidic pH. This idea is substantiated by the high abundance of NHE-1 in the skin 
constructs already at day 4. This result is in good agreement with previous findings 
that FLG-UCA/PCA pathway is not essential for SC acidification [8] and that NHE-1 is 
the primary source of acidic microdomains activating lipid processing enzymes [35]. 
At day 7 the lack of FLG becomes apparent as UCA/PCA values are significantly lower 
in FLG- constructs. NHE-1 is still able to maintain an acidic pH but is significantly 
upregulated in FLG-, which is likely a compensatory mechanism of the decreased 
UCA/PCA-based acidity. At this time point, FLG+ and FLG- constructs are still very 
similar as also indicated by the skin lipid arrangement and permeability being in a good 
agreement with [19], who cultivated their models for 7 days. The most pronounced 
consequences of FLG deficiency appear at later time points due to the progressive 
differentiation and maturation of the skin constructs. At day 14, NHE-1 is still 
upregulated in FLG- constructs but now another acidification mechanism is activated: 
the PL-FFA conversion by sPLA2. The importance of NHE-1 and sPLA2 for skin 
acidification has been demonstrated before [36,37]. While this happens in both FLG- 
and FLG+ constructs, the expression and activity of sPLA2 are significantly higher in 
the FLG-. Thus, although the time-course of NHE-1 and FFA-based acidification 
pattern of the skin constructs is not affected by deficient FLG, these two pathways are 
upregulated to compensate for the lack of FLG-His-UCA/PCA.  
The question is what exactly is the trigger activating the other acidification pathways. 
As we did not detect any differences in pH between FLG+ and FLG-, it seems that 
these compensatory mechanisms are activated by very small or localized pH changes 
that we are not able to measure. Another possibility is that pH does not control 
acidification itself but by the levels of products or intermediates of other acidification 
pathways. The latter possibility would be more advantageous as it would prevent pH 
changes rather than correct them.     
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Nevertheless, we cannot exclude that there are other key players involved in the 
acidification process which have not yet been identified as also suggested by [35]. Our 
findings are well in line with [8] and substantiate the idea of compensatory mechanism 
between different pathways to ensure skin acidification.  
In conclusion, the decreased levels of UCA/PCA accompanied by an increase of NHE-
1 and later sPLA2 IIA in FLG- constructs demonstrate an interplay between different 
skin acidification pathways. Fig. 5 displays the suggested processes of skin 
acidification. Additionally, using in vitro skin constructs we showed that FLG deficiency 
directly influences the skin lipid orientation by increasing the amount of FFA and, thus, 
affecting skin permeability. Our results considerably contribute to the understanding of 
skin acidification and the impact of FLG deficiency on skin barrier dysfunction. To our 
best knowledge, these direct interdependencies have not been described before. 
 
 
Figure 3-5 Stratum corneum pH unifying concept. In FLG deficiency, NHE-1 and sPLA2 are 
upregulated to maintain the acidic pH needed for a variety of skin functions. Adapted and 
modified from Fluhr et al., 2001 [37]. 
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3.5 MATERIALS AND METHODS 
Non-hydroxy and α-hydroxy sphingosine-based ceramides (Cer NS and AS), GCer, 
SM, GSph, and SPC were purchased from Avanti Polar Lipids (Alabaster, USA). 
Phytoceramide (Cer NP) was prepared by acylation of phytosphingosine with 
lignoceric acid as described previously [38,39]. The structure and purity of the prepared 
Cer NP were confirmed by 1H and 13C NMR spectra (Varian Mercury-Vx BB 300 
instrument, operating at 300 MHz for 1H, 75 MHz for 13C), MS (Agilent 500 Ion Trap 
LC/MS), and infrared spectra (Nicolet 6700 FT-IR spectrophotometer). Chol and all 
other chemicals were from Sigma-Aldrich (Schnelldorf, Germany). Radiolabelled 
1,2,6,7-3H-testosterone was from Amersham, Freiburg, Germany. Radiolabelled 1-
methyl-14C-caffeine was from Arc Inc., St. Louis, USA. 
3.5.1 PREPARATION OF SKIN CONSTRUCTS 
The skin constructs (FLG+ and FLG-) have been generated according to [16,40]. SC 
was isolated after 4, 7 and 14 days. The constructs were placed on a filter paper 
soaked in 0.5  % trypsin in phosphate-buffered saline (PBS, pH 7.4) (Kligman and 
Christophers, 1963). The isolated SC sheets were washed with PBS and any 
remaining keratinocytes were removed with a cotton swab. Subsequently, SC sheets 
were washed with acetone to remove surface contaminants, vacuum-dried and stored 
at -20°C. Isolated human SC served as control.  
 
3.5.2 FOURIER TRANSFORM INFRARED (FTIR) SPECTROSCOPY  
IR spectra of the samples were collected on a Nicolet 6700 FT-IR spectrometer 
(Thermo Scientific, USA) equipped with a single-reflection MIRacle attenuated total 
reflectance (ATR) germanium crystal at 23 °C. The spectra were generated by co-
addition of 256 scans collected at 4 cm-1 resolution and analyzed with the Bruker OPUS 
software. The exact peak positions were determined from second derivative spectra 
and by peak fitting if needed.  
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3.5.3 ISOLATION OF SC LIPIDS 
For the extraction of the SC intercellular lipids, a modified [41] method was used. The 
SC samples were extracted with 1 ml CHCl3/MeOH 2:1 (v/v) per mg of SC for 1.5 h, 
filtered, separated and concentrated under a stream of nitrogen. The lipids were dried 
and stored at -20°C under argon.  
 
3.5.4 HPTLC LIPID ANALYSIS 
The lipid analysis was performed on silica gel 60 HPTLC plates (20 × 10 cm, Merck, 
Darmstadt, Germany). The extracted SC lipids were dissolved in 100 µl CHCl3/MeOH 
2:1. 10 µl of each lipid sample was sprayed on the plate using a Linomat IV (Camag, 
Muttenz, Switzerland). Standard lipids were dissolved in CHCl3/MeOH 2:1 (v/v) (Cer 
NS, AS, NP, Chol, and palmitic acid), CHCl3/MeOH 1:1 (v/v) (CholS, GCer and SM), 
and MeOH (GSph and SPC), respectively, at 1 mg/ml. They were first analyzed 
separately during method development and then mixed at 50 µg/ml and applied on a 
HPTLC plate together with the analyzed samples to generate calibration curves from 
50 ng to 7.5 µg. The major skin barrier lipids (Cer, FFA and Chol) were separated using 
CHCl3/MeOH/acetic acid 190:9:1.5 (v/v/v) mobile phase twice to the top of the plate 
(Bleck et al., 1999). The Cer precursors (GlcCer and SM), their degradation products 
(GSph and SPC) and CholS were separated using a more polar mobile phase 
(CHCl3/MeOH/acetic acid/H2O 65:25:6:3). The lipids were visualized by dipping in a 
derivatization reagent (7.5% CuSO4, 8% H3PO4, 10% MeOH in water) for 10 s and 
heating at 160 °C for 30 min and quantitated by densitometry using TLC scanner 3 and 
WinCats software (Camag, Muttenz, Switzerland). 
 
3.5.5 DETERMINATION OF FLG, SPLA2 AND NHE-1 EXPRESSION 
For isolation of RNA the constructs were harvested at day 14 and punched to discs 
(10 mm). Epidermis was frozen using liquid nitrogen and then milled for 30 s at 25 Hz 
using a TissueLyzer (Qiagen, Hilden, Germany). Subsequently, RNA was isolated 
using NucleoSpin® RNA II according to the manufacturer’s instructions. For cDNA 
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synthesis RevertAidTM First Strand cDNA Synthesis Kit was used according to 
manufacturer’s instruction.  
For relative quantification of FLG, NHE-1 and sPLA2 isoforms expression reverse 
transcription polymerase chain reaction (RT-PCR) was performed using the SYBR 
Green I Masterplus kit (Roche, Penzberg, Germany). For primer sequences see Tab. 
S2. The house-keeping gene YWHAZ served as control.  
 
3.5.6 SKIN SURFACE PH MEASUREMENTS 
Luminescent 2D-imaging of pH [42,43] was performed via RGB-imaging [42] of pH 
sensor foils consisting of a hydrogel layer containing pH-indicator microparticles 
(fluorescein isothiocyanate bound to aminoethylcellulose) and reference particles 
[ruthenium(II)-tris(4,7-diphenyl-1,10-phenanthroline) incorporated in polyacrylonitrile]. 
Sensor foils were gently applied to 3D skin construct surfaces and they were allowed 
to slowly adapt by adhesion forces. Calculations and pseudocolor image processing 
were done with ImageX software (Microsoft Corporation) and ImageJ 
(http://rsbweb.nih.gov/ij/). For details see Supplemental methods. 
 
3.5.7 IMMUNOHISTOCHEMISTRY  
After 14 days, the constructs were embedded in tissue freezing medium (Leica 
Microsystems, Nussloch, Germany) and frozen using liquid nitrogen. After overnight 
storage at -80°C, the constructs were cut to vertical slices (5 µm) with a freeze 
microtome (Leica Microsystems, Nussloch, Germany). After fixation, they were 
washed with PBS containing 1% bovine serum albumin (BSA) and blocked with normal 
goat serum (1:20 in PBS). The sections were incubated for one hour with primary rabbit 
antibodies specific against NHE-1 and sPLA2-IIA (Abcam, Cambridge, UK) diluted in 
PBS containing 1% BSA (1:400 and 1:200, respectively) and subsequently with goat-
anti-rabbit IgG DyLight 488 antibody (Dianova, Hamburg, Germany). After washing, 
the sections were embedded in antifading mounting medium (Dianova, Hamburg, 
Germany) and analyzed with a fluorescence microscope (BZ-8000, Keyence, Neu-
Isenburg, Germany). 
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3.5.8 SKIN PERMEABILITY TESTING 
The skin permeability was evaluated according to validated test procedures (Schäfer-
Korting et al., 2008). Briefly, stock solutions of testosterone (40 µg/ml, 2% [v/v] Igepal® 
CA-630) and caffeine (1 mg/ml) were spiked with an appropriate amount of the 
radiolabelled compound to achieve a total radioactivity of 2 µCi/ml. Permeation studies 
were performed at day 7 using a static setup (Franz type diffusion cells, diameter 15 
mm, volume 12 ml, Permegear, Bethlehem, USA). 
3.5.9 STATISTICAL ANALYSIS 
Wilcoxon signed rank test or t-test were used when comparing two different conditions 
according to the results of D'Agostino-Pearson normality test. When comparing three 
or more conditions, a one-way analysis of variance (ANOVA) with a Bonferroni post-
hoc test or Friedman plus Dunn's tests were performed using SigmaStat for Windows 
3.5 (SPSS, U.S.A.). p ≤ 0.05 was considered significant. The data are presented as 
means ± SEM. 
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4.1 ABSTRACT 
An acidic skin surface pH is crucial for correct skin homeostasis. While many common 
skin diseases such as atopic dermatitis demonstrate increased skin surface pH values, 
the underlying mechanism is still elusive. Here we establish a sodium/hydrogen 
exchanger 1 (NHE-1) knockdown (KD) and a filaggrin (FLG)/ NHE-1 double KD in 
reconstructed skin models to gain deeper insight into the impact of intrinsic contributors 
to the acidic skin surface. NHE-1 KD leads to slightly elevated pH values, while the KD 
of both NHE-1 and FLG did not result in further pH increase. NHE-1 KD alone resulted 
in decreased FLG expression. Overall, contributors like NHE-1 or secretory 
phospholipases seem to be more important for pH maintenance than the structural 
protein filaggrin and its degradation products. Other, yet unknown pathways likely take 
part in the regulation of skin surface pH.  In general, reconstructed skin models in 
combination with RNA interference are a suitable tool to access the impact of single 
genes and proteins on a complex issue like skin surface pH. 
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4.2 INTRODUCTION  
The acidic pH of the skin surface (pH 5.5) is pivotal to the homeostasis and integrity of 
the human skin [1–3]. The outermost layer of human skin, the stratum corneum (SC), 
consists of tightly packed corneocytes embedded within organized lipid lamellae 
composed of free fatty acids, cholesterol and ceramides, forming an essential barrier 
against the  entry of xenobiotics and microorganism, as well as against extensive water 
loss from the body [4]. Ceramides are generated from β-D-glucosylceramides or 
sphingomyelins by β-glucocerebrosidase and acidic sphingomyelinase catalysed 
hydrolysis, enzymes that exhibit activity maximums at acidic pH values [5–7]. Skin 
diseases such as ichthyosis vulgaris and atopic dermatitis are often associated with 
increased skin surface pH [8–10], which in turn may diminish enzymatic activities 
resulting in reduced ceramide levels and hampered formation of the SC lamellar lipid 
bilayers [7,10]. The underlying reasons for these increased pH values is still not fully 
understood, nor are the exact mechanisms that maintain and regulate the surface pH 
of skin. Though it was once hypothesized that acidic surface pH resulted from 
sebaceous and eccrine gland secretions and/or bacterial byproducts like lactic acid, it 
is now known that three intrinsic mechanisms are significantly contributing : [1] free 
fatty acids generated from phospholipids by secretory phospholipases A2, [2] 
expression of sodium/hydrogen exporter 1 (NHE-1) and [3] the filaggrin-histidine-
urocanic acid/pyrrolidonic acid pathway [11,12]. Mutations in the filaggrin gene (FLG) 
are the underlying cause of ichthyosis vulgaris (IV) and a major predisposing factor for 
the manifestation of atopic dermatitis (AD) [13,14]. Hence, the increased skin surface 
pH in patients suffering from IV or AD is often linked  to a lack of filaggrin [15]. However, 
it has been demonstrated that FLG deficiency alone does not result in increased skin 
surface pH [16,17]. This might be explained by the recent identification of a feedback 
mechanism that compensates for a lack of FLG by upregulating NHE-1 expression and 
increasing sPLA2 activity [17]. Nevertheless, ultimate impact of NHE-1 on the skin 
surface pH is unclear. 
Thus, the aim of this study was to establish a NHE-1 KD skin model and a FLG/NHE-
1 double KD model using RNA interference, so as to investigate the interdependencies 
between FLG and NHE-1 on skin acidification. Moreover, to the best of our knowledge, 
the feasibility of establishing a double KD skin model for basic research has yet to be 
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demonstrated and as such, systematic optimizations of those conditions required for 
efficient double gene KD in skin models were performed. Following successful 
establishment, KD efficiency was assessed at the mRNA and protein level, and the 
impact these had on skin model physiology investigated by histology and assessment 
secretory phospholipases expression and measurement of skin surface pH.  
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4.3 METHODS 
4.3.1 CELL CULTURE  
Primary human fibroblasts and keratinocytes were isolated from juvenile foreskin (with 
written consent). Briefly, foreskins were cut into small pieces and incubated overnight 
with Dispase II (Roche Diagnostics, Mannheim, Germany). The epidermis and dermis 
were separated using forceps. For keratinocyte isolation, the epidermis was further 
treated with trypsin/EDTA solution for 5 min at 37°C (Biochrome, Berlin, Germany). 
Afterwards, keratinocytes were cultured in keratinocyte growth medium (Lonza, 
Cologne, Germany). The dermis was cultured in DMEM (Sigma-Aldrich, Taufkirchen, 
Germany) containing 5 mM L-glutamine and 10% FBS (Biochrome, Berlin, Germany) 
until outgrowth of the fibroblasts occurred. Media changes were performed every other 
day. For all experiments, cell passages 2 or 3 were used.  
  
4.3.2 NHE-1 KD 
To identify optimal KD conditions, three different NHE-1-specific siRNAs (siRNA 1, 
HSS109888, siRNA 2 HSS109889, siRNA 3 HSS109889, Life Technologies, 
Darmstadt, Germany) were tested in primary human keratinocytes at concentrations 
ranging from 10 to 50 nM. HiPerfect (Qiagen, Hilden, Germany) served as transfection 
reagent, and was used at concentrations ranging from 1.5 to 4.5 µl/ml. KD efficiencies 
were assessed 24 h and 48 h post transfection. A non-coding siRNA served as 
negative control (Life Technologies, Darmstadt, Germany). 
 
4.3.3 CONSTRUCTION OF SKIN MODELS 
In vitro skin models were generated according to previously published procedures 
[18,19]. Briefly, bovine collagen (Cellsytems, Troisdorf, Germany) was mixed with 10-
fold Hanks balanced salt solution (Life Technologies, Darmstadt, Germany) and 
brought to a neutral pH. Afterwards, 2.5 x 105 fibroblasts (per skin model) were added 
and 2.5 ml of the mixture was poured into 6-well cell culture inserts (VWR, Ismaning, 
Germany). After solidification at 37° C for 2h, 4.2 x 106 normal or transfected 
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keratinocytes were added to the top of the collagen matrix. 24h on, the skin models 
were lifted to the air-liquid interface and the medium changed to a differentiation 
medium. Skin models were cultivated for up to 14 days with a media change every 
other day.  
To generate FLG KD skin models, keratinocytes were transfected prior to seeding 
using FLG-specific siRNAs (HSS177192, Life Technologies, Darmstadt, Germany) 
[19]. KD efficiency was determined by quantitative reverse transcription polymerase 
chain reaction (RT-PCR). 
 
4.3.4 RT-PCR 
Skin constructs were punched to 10 mm discs, and the viable epidermis gently peeled-
off, frozen and then milled. Subsequently, RNA was isolated using the NucleoSpin® 
RNA II kit (Macherey-Nagel, Düren, Germany) according to the manufacturer’s 
instructions. For cDNA synthesis, RevertAidTM First Strand cDNA Synthesis Kit 
(Thermo Scientific, Waltham, MA, USA) was used. For relative gene expression 
quantification, RT-PCR was performed using the Power SYBR® Green PCR Master 
Mix (Life Technologies, Darmstadt, Germany). The primer sequences are listed in 
supplementary Table 4-1. YWHAZ served as house-keeping gene. 
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Table 4-1 Primer sequences for PCR analysis 
Gene Primer sense 5’-3’ Primer antisense 5’-3 
YWHAZ AGACGGAAGGTGCTGAGAAA GAAGCATTGGGGATCAAGAA 
FLG AAGGAACTTCTGGAAAAGGAATTTC TTGTGGTCTATATCCAAGTGATCCAT 
NHE-1 AGATCCAGGCTTCTCCCGGAC CCATGTGCCTGGTACCCCTGGT 
sPLA2-IB GCAATCACCTGTAGCAGCAA GTCCAGGTTCTTGTGTGCCT 
sPLA2-IIA ACCCTCCCTCCCTACCCTAAC AATCTGCTGGATGTCTCATTCTGG 
sPLA2-IIF GACCCACACCCTCTCTCC GATGCTCTCCCTGCTTACG 
sPLA2-V CTGCCTGGTTCCTGAGAGAG CAACCCTGAGTTGGAGGAGA 
sPLA2-XIIA TAGCTGTCGGCATCTCCTTT GGCATGTGAAACAACAGTGG 
 
4.3.5 WESTERN BLOT 
For Western blot analysis of FLG and NHE-1, skin models or keratinocytes were lysed 
in RIPA buffer containing proteases inhibitor (New England Biolabs, Frankfurt/Main, 
Germany), centrifuged for 30 min at 14,000 × g and the supernatant subsequently 
stored at -80°C until use. The total amount of protein was quantified via BCA protein 
assay (Thermo Scientific, Waltham, USA). 30 µg of each protein sample was incubated 
at 95°C in standard SDS-PAGE buffer and separated via 10% SDS polyacrylamide gel 
electrophoresis (Bio-Rad, Munich, Germany). Gels were blotted onto Immobilon P 
nitrocellulose membranes (Carl Roth, Karlsruhe, Germany) via Trans-Blot® Turbo™ 
Transfer System (Bio-Rad, Munich, Germany). After blocking with 5% non-fat dry milk 
in tris-buffered saline -Tween 20 (0.1%) for 1 h, the membranes were incubated with 
primary antibodies (filaggrin antibody ab81468, NHE-1 antibody ab67313, Abcam, 
Cambridge, UK) overnight. Subsequently, the membranes were washed and incubated 
with anti-rabbit horseradish-peroxidase-conjugated secondary antibody (Cell 
Signaling, Frankfurt/Main, Germany) at room temperature for 1 h. All blots were 
4. Establishment of a double knockdown skin model to investigate the impact of filaggrin and sodium/hydrogen 
antiporter 1 on skin acidification 
 
 
54 
 
developed with SignalFire™ ECL reagent (Cell Signaling, Frankfurt/Main, Germany) 
and visualized by a PXi/PXi Touch gel imaging system (Syngene, Cambridge, UK). 
 
4.3.6 HEMATOXYLIN-EOSIN (H&E) STAINING AND IMMUNOFLUORESCENCE  
Skin constructs were embedded in tissue freezing medium (Leica Microsystems, 
Nussloch, Germany) and shock-frozen using liquid nitrogen. Afterwards, vertical 
cryosections (5 µm) were prepared using a cryotome (Leica Microsystems, Nussloch, 
Germany). For histological analysis, H&E staining was performed according to 
standard procedures. For immunostaining against FLG and NHE-1 the skin sections 
were stained with filaggrin antibody ab81468 (1:200) or NHE-1 antibody ab67313 
(1:400), (Abcam, Cambridge, UK) respectively, and counterstained with DAPI. 
Sections were analyzed using the fluorescence microscope BZ-8000 (Keyence, Neu-
Isenburg, Germany). 
 
4.3.7 SKIN SURFACE PH MEASUREMENTS 
For surface pH measurements of the skin models, optical sensor foils containing pH-
indicator microparticles (fluorescein isothiocyanate) and reference microparticles 
(ruthenium(II)-tris(4,7-diphenyl-1,10-phenanthroline)) were applied onto the skin 
models [17,20]. The luminophores were excited with a 460-nm LED array and a RGB 
image was recorded using a commercial camera. The red channel contained the 
reference signal, while the green channel recorded the pH depended signal. Channel 
intensity ratios enabled the calculation of the pH at every pixel in the image with 
ImageX software (Microsoft Corporation) and ImageJ (http://rsbweb.nih.gov/ij/). 
Reported values were averaged from 4 separate skin models. 
 
4.3.8 STATISTICAL ANALYSIS 
The data were statistically analyzed using ANOVA and one-sample t-test and p ≤ 0.05 
was defined as the level of significance. 
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4.4 RESULTS  
4.4.1 ESTABLISHMENT OF NHE-1 AND FILAGGRIN/NHE-1 DOUBLE KD SKIN 
MODELS  
To achieve a sound NHE-1 KD, the efficacies of different siRNA concentrations in 
combination with different transfection agent concentrations were evaluated in primary 
human keratinocytes.  Exemplary transfection with siRNA 2 is shown in Figure 4-1 A. 
The combination of 50 nM siRNA and 4.5 µl/ml HiPerfect yielded the best silencing (≥ 
77 ± 9.5%). No KD was observed after transfection with 50nM non-coding siRNA and 
4.5 µl/ml HiPerFect at mRNA (Fig. 4-1 B) and protein level (Fig. 4-1 C). 
All three NHE-1 specific siRNA sequences, alone or in combination, were tested at 50 
nM with 4.5 µl/ml HiPerFect (Fig. 4-2 A). While distinct NHE-1 KD was observed in all 
instances, siRNA 2 and 3 were superior to siRNA 1, with KD rates of 75.2 ± 4.1%, 86.9 
± 6.2% and 45.2 ± 1.5%, respectively. Combination of all three siRNAs produced no 
further improvements to KD efficiency. Concordant data were observed at the protein 
level, where siRNA 2 produced the most effective KD of NHE-1 (Fig. 4-2 B). 
Subsequently 50nM siRNA 2 (HSS 109889) with 4.5 µl HiPerFect was chosen for 
further experiments.   
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Figure 4-1 Relative mRNA expression of NHE-1 in normal human keratinocytes 48 h after (A) 
siRNA 2 and (B) non-coding siRNA transfection quantified by RT-PCR, mean ± SEM, n = 3. 
(C) Protein expression of NHE-1 and β-actinin in normal human keratinocytes untreated and 
non-coding siRNA transfected.  
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Figure 4-2 (A) Relative mRNA expression of NHE-1 and (B) protein expression of NHE-1, FLG 
and β-actin in normal human keratinocytes 48 h post transfection. (C) Relative mRNA 
expression of FLG (white) and NHE-1(grey bars) and (D) protein expression of NHE-1, FLG 
and β-actin in skin models. Relative mRNA expression quantified by RT-PCR; mean ± SEM, n 
= 3, *p ≤ 0.05, ***p ≤ 0.001. 
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 For disease skin model generation, keratinocytes were transfected with FLG- 
(HSS177192) or NHE-1- (HSS109889) specific siRNA sequences alone or in 
combination NHE-1 and FLG KDs were performed 48h and 24h prior seeding, 
respectively. In the fully formed skin models, a KD efficiency of 90.5 ± 3.1% for NHE-
1 was achieved (Fig. 4-2 C), and KD efficiencies of 81.6 ± 4.1% and 86.3 ± 1.8% for 
NHE-1 and FLG respectively in the double KD skin models. KDs were confirmed by 
western blot and immunostaining (Fig. 4-2 D and Fig. 4-3 E-H). Unexpectedly, a slight 
reduction in FLG expression, both at the mRNA and protein level, was seen in the 
NHE-1 KD models (Fig. 4-3). 
 
4.4.2 SKIN MODEL CHARACTERIZATION 
In line with previous publications, the FLG deficient skin model was characterized by 
disturbed epidermal maturation and differentiation as compared with the normal skin 
model (Fig. 4-3 B) [19]. These effects were even more pronounced in the NHE-1 and 
FLG/NHE-1 KD skin models (Fig. 4-3 C, D).  
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Figure 4-3 Representative histological pictures of (A) normal, (B) FLG KD, (C) NHE-1 KD and 
(D) FLG/NHE-1 KD models after 14 days cultivation. Immunostaining against filaggrin (green) 
and NHE-1 (red) in (E) normal, (F) FLG KD, (G) NHE-1 KD and (H) FLG/NHE-1 KD models. 
The cell nuclei were counterstained with DAPI (blue fluorescence), 20× magnification, scale 
bar = 50 µm.  
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4.4.3 SKIN SURFACE PH MEASUREMENTS  
Normal skin models exhibited a skin surface pH of 5.45 ± 0.1. No significant differences 
between normal and filaggrin-deficient skin models were detected. NHE-1-deficient 
models showed a significant increased to pH 5.66 ± 0.1 (n=4, *p < 0.05). Similarly, 
FLG/NHE-1 KD models demonstrated a surface pH of 5.62 ± 0.1. Representative 
images of the skin surface pH measurements are shown in Figure 4-4. 
 
Figure 4-4 Representative skin surface pH of skin models at day 14 of tissue cultivation using 
RGB-imaging luminescent 2D-imaging. 
 
4.4.4 SPLA2 EXPRESSION 
To investigate the influence of filaggrin and NHE-1 deficiencies on the expression of 
different sPLA2 subtypes, relative mRNA expressions of sPLA2 IB, IIF, IIA, V, X and 
XIIA were analyzed. No significant differences between the normal, NHE-1 or 
FLG/NHE-1 deficient skin models were detected for sPLA2 IB, IIF, V, X and XIIA (Fig. 
4-5). The expression of sPLA2 IIA was too low to be assessed.  
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Figure 4-5 Relative mRNA expression of sPLA2 1B, 2F, V, X and IIA in NHE-1 and FLG/NHE-
1 KD skin models quantified by RT-PCR; mean ± SEM, n = 4. 
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4.5 DISCUSSION  
Skin models are important tools for the investigation of complex physiological and 
pathophysiological processes [21,22]. Using RNA interference, specific genes of 
interest can be knocked down in order to study their impact on skin homeostasis. The 
aim of the present study was to develop and characterize a FLG/NHE-1 double KD 
skin model to the feasibility of a double KD approach, and to investigate the impact of 
filaggrin and NHE-1 deficiencies on the skin surface pH.  
Filaggrin is an important structural protein in the human epidermis, where mutations in 
FLG are known to cause ichthyosis vulgaris and act as a major predisposing risk factor 
to the manifestation of atopic dermatitis [14]. The hypothesis that filaggrin degradation 
is essential for skin acidification was recently challenged  by several groups [16,17,23]. 
NHE-1, the only sodium hydrogen antiporter isoform expressed in keratinocytes, 
regulates  intracellular pH, cellular volume and acidifies extracellular ‘microdomains’ of 
the upper epidermis [12,24]. Moreover, it is upregulated in instances of FLG deficiency 
[17]. While an important role for NHE-1 in skin acidification has been suggested, its 
exact role has remained elusive.   
In the present study, NHE-1 KD resulted in a moderate but statistically significant 
increase in the surface pH of skin models (Fig. 4). Whilst it was clear NHE-1 KD 
reduced the NHE-1 protein expression, it is still unknown exactly how many active 
proton pumps are required to maintain skin surface pH.  Residual NHE-1 levels post 
KD may be sufficient for substantial acidification and could explain the moderate 
increase in skin surface pH. The increase in skin surface pH is concordant with 
previously published work, where  topical treatment with a specific NHE-1 inhibitor led 
to only slight pH elevations in neonatal rats [23], and NHE-1 knockout mice displayed 
similarly mild increased in surface pH compared to wild-type [12]. In contrast to these 
studies, the data presented here was acquired by an in vitro approach, avoiding animal 
experiments. The use of human primary keratinocytes also ensures the absence of 
interspecies disparities.   
Interestingly, the double KD of FLG and NHE-1 resulted in similar pH values as the 
single NHE-1 KD. We previously  identified a compensatory upregulation of NHE-1 in 
filaggrin deficient skin, indicating a feedback mechanism to maintain the skin surface 
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pH [17]. The deficiency of both, however, did not further increase the pH.  Comparable 
results were described by Fluhr et al., where inhibition of NHE-1 or sPLA2 slightly 
increased the pH values and delayed postnatal SC acidification, but simultaneous 
inhibition of both did not lead to further detrimental effects [25]. A similar scenario is 
suggested for NHE-1 and filaggrin. Beyond that, NHE-1 KD led to reduced amounts of 
FLG in skin models, which might provide a further explanation why the NHE-1 KD and 
the FLG/NHE-1 KD do not relevant differ. The reduced amount of FLG in NHE-1 KD 
models may originate from an impaired skin differentiation. 
Furthermore, if inhibition of the known contributors to skin acidification such NHE-1 
does not lead to a shift to the near neutral surface pH, other thus far undiscovered 
pathways may well be involved. 
In conclusion, we have shown that it is possible to knock down the two genes, FLG 
and NHE-1, at the same time in reconstructed skin models. Furthermore, we confirmed 
that NHE-1 is important for the formation and maintenance of epidermis and 
contributes to the skin acidification. The contribution of FLG to the acidity of the skin is 
inferior, also when NHE-1 is lacking.  
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5.1 ABSTRACT 
Reconstructed skin models are suitable test systems for toxicity testing and for basic 
investigations on (patho-)physiological aspects of human skin. Reconstructed human 
skin, however, has clear limitations such as the lack of immune cells and a significantly 
weaker skin barrier function compared to native human skin. Potential reasons for the 
latter might be the lack of mechanical forces during skin model cultivation which is 
performed classically in static well-plate set-ups. Mechanical forces and shear stress 
have a major impact on tissue formation and, hence, tissue engineering. 
In the present work, a perfusion platform was developed allowing dynamic cultivation 
of in vitro skin models. The platform was designed to cultivate reconstructed skin at 
the air-liquid interface with a laminar and continuous medium flow below the dermis 
equivalent. Histological investigations confirmed the formation of a significantly thicker 
stratum corneum compared to the control cultivated under static conditions. Moreover, 
the skin differentiation markers involucrin and filaggrin as well as the tight junction 
proteins claudin-1 and occludin showed increased expression in the dynamically 
cultured skin models. Unexpectedly, despite improved differentiation, the skin barrier 
function of the dynamically cultivated skin models was not enhanced compared with 
the skin models cultivated under static conditions.  
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5.2 INTRODUCTION  
Safety and risk assessment procedures for drugs and the demand to improve 
standards and knowledge about these topics goes along with constantly high numbers 
of animal experiments in the European Union [1]. However, ethical standards of the 
modern society and low predictive power of animal models [2,3] call for the avoidance 
or reduction of animal experiments whenever possible. Hence, academia and 
pharmaceutical industry are working on the establishment of alternative test systems 
in accordance with the 3R’s principle established in 1959: the replacement, reduction 
or refinement of animal experiments. To bring in line the need for powerful test systems 
and the avoidance of animal experiments, alternative approaches, often based on 
tissue engineering, are investigated and improved [4,5]. Especially for human skin a 
whole slew of methods is available today.  
Reconstructed human epidermis and full-thickness skin models are commercially 
available and validated by the OECD for skin irritation and corrosion testing. 
Additionally, they are accepted for testing skin absorption taking into account the 
generally higher permeability of in vitro skin models [6–8]. Moreover, skin models are 
used for the assessment of drugs’ pharmacodynamics or side effects [9] and for 
fundamental studies on (patho-)physiological mechanism [10–12]. Nevertheless, in 
vitro skin models clearly have limitations compared to native human skin such as lower 
mechanical resistance, impaired maturation and differentiation, altered skin lipid 
composition and organization [13,14], increased skin permeability [15] and a lack of 
complexity, e.g. missing immune cells or systemic circulation [16]. 
The reasons for the altered skin lipids and the weakened skin barrier function are 
diverse. All tissues in the human body are constantly subjected to forces such as 
pressure, fluid shear stress, stretch or compression. Mechanical forces are crucial for 
normal tissue homeostasis and remodeling and influence fundamental cellular events 
such as cell division [17–19]. These basic principles depict the importance of 
mechanical forces also for tissue engineering. Various publications have described 
beneficial effects of mechanical forces when applied on reconstructed tissue such as 
artificial cartilage or lung tissue [19–22]. Additionally, responses of human skin cells to 
electrical field stimulation, such as an accelerated alignment of fibroblasts, has been 
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described [23]. Thus, the lack of specific biophysical and biochemical signaling or 
mechanical forces and shear stress during cultivation under static conditions in well 
plates may considerably contribute to the less efficient barrier function of skin models 
[24,25]. Furthermore, skin models do not have an active nutrient supply through 
capillaries and they lack the effect of convection and dependent on nutrient supply by 
diffusion.  
Hence, to improve the quality of in vitro skin models and to investigate the impact of 
mechanical forces on skin homeostasis, a perfused bioreactor was constructed 
allowing the cultivation of skin models at the air liquid interface and providing a 
continuous flow of cultivation medium at the basal side. Following development of the 
bioreactor optimized medium flow rates and velocities were determined followed by 
investigating their impact on skin differentiation and maturation, the expression of skin 
barrier and tight junction proteins was investigated, and the skin barrier function was 
determined.  
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5.3 MATERIALS AND METHODS 
5.3.1 CONSTRUCTION OF PERFUSION PLATFORM 
The perfusion platform was constructed for Falcon 6-well cell culture inserts (VWR, 
Darmstadt, Germany). The design drawing was performed using 3D CAD Design 
Software SolidWorks (Dassault Systèmes S.A., Vélizy-Villacoublay, France). The test 
systems were manufactured at research workshop of the Faculty of Chemistry and 
Pharmacy, LMU Munich. The platform is composed of polytetrafluoroethylene (PTFE) 
to allow steam sterilization.  
5.3.2 CELL CULTURE 
Primary human fibroblasts and keratinocytes were isolated from juvenile foreskin 
according to standard procedures (approved by the ethics committee of the LMU 
Munich, with written consent) [26]. Briefly, epidermis and dermis were separated after 
overnight incubation with Dispase II (1.2 U/mL in PBS, Roche Diagnostics, Mannheim, 
Germany). The separated epidermis was treated with trypsin/EDTA (2,5 mg/mL 
trypsin, 1 mmmol/L EDTA, Biochrome, Berlin, Germany) for 5 min at 37°C to 
singularize keratinocytes. To cultivate primary keratinocytes, keratinocyte growth 
medium (Lonza, Cologne, Germany) was used. After outgrowth from the dermis, 
fibroblasts were further cultivated in DMEM (Sigma-Aldrich, Taufkirchen, Germany) 
containing 5 mM L-glutamine and 10% FBS (Biochrome, Berlin, Germany). Media was 
changed every other day and the cells were used at passage 2 or 3. 
5.3.3 CONSTRUCTION OF SKIN MODELS 
In vitro skin models were generated according to previously published procedures 
[27,28]. Briefly, bovine collagen (3 mg/mL, Cellsytems, Troisdorf, Germany) was mixed 
with 10-fold Hanks balanced salt solution (Thermo Scientific, Darmstadt, Germany) 
and brought to neutral pH. Afterwards, 2.5 x 105 fibroblasts (per skin model) were 
added and 2.5 ml of the mixture was poured into 6-well cell culture inserts (pore size: 
3 µm, surface area 4.2 cm2, 2x106 pores/cm2, PET membrane, VWR, Ismaning, 
Germany). After solidification at 37° C for 2h, 4.2 x 106 normal keratinocytes were 
added on top of the collagen matrix. 24h later, the skin models were lifted to the air-
liquid interface and the medium was changed to a differentiation medium. At this stage, 
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the skin models were transferred to the perfusion platform and grown for six more days. 
Skin models cultivated in static 6-well plates served for reference. 
5.3.4 HEMATOXYLIN-EOSIN (H&E) STAINING 
Skin models were punched and immediately embedded in tissue freezing medium 
(Leica Microsystems, Nussloch, Germany). The embedded models were shock-frozen 
using liquid nitrogen and stored for 12h at -80°C. Vertical 7 µm thick cryosections (at 
an angle of 90°) were prepared using a cryotome (Leica Microsystems, Nussloch, 
Germany). A standard H&E staining procedure was performed for histological analysis. 
The skin sections were analyzed using the microscope BZ-8000 (Keyence, Neu-
Isenburg, Germany). 
5.3.5 THICKNESS MEASUREMENTS 
The thickness of the stratum corneum was measured from the top of the skin models 
to the beginning of the viable epidermis, directly below the straum corneum. Viable 
epidermal thickness was measured from below the stratum corneum to the beginning 
of the dermal equivalent in three H&E stained sections (per skin equivalent). Dermal 
thickness measurement was performed from the beginning of the dermis equivalent to 
the beginning of the cell culture insert. In total, ten measuring points were evaluated in 
each section using BZ image analysis software, respectively (Keyence, Neu-Isenburg, 
Germany). 
5.3.6 REAL-TIME POLYMERASE CHAIN REACTION (QPCR) 
Skin models were punched to discs of 10 mm diameter. The epidermis was peeled-off 
and immediately frozen in liquid nitrogen. The frozen epidermis was subsequently 
milled with a CryoMill (RETSCH GmbH, Haan, Germany). RNA was isolated using the 
NucleoSpin® RNA II kit (Macherey-Nagel, Düren, Germany) according to the 
manufacturer’s instructions. RNA was treated with DNase 1 (Sigma-Aldrich, 
Taufkirchen, Germany). For cDNA synthesis, RevertAidTM First Strand cDNA 
Synthesis Kit (Thermo Scientific, Waltham, MA, USA) was used. For relative gene 
expression quantification, quantitative PCR was performed using the Power SYBR® 
Green PCR Master Mix (Thermo Scientific, Darmstadt, Germany) and the qTower 2.2 
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PCR cycler (Analytik Jena AG, Jena, Germany). The primer sequences (Tib Molbiol, 
Berlin, Germany) are listed in Table 5-1. YWHAZ served as house-keeping gene. 
 
Table 5-1 Primer sequences for PCR. 
Gene Primer sense 5’-3’ Primer antisense 5’-3 
YWHAZ AGACGGAAGGTGCTGAGAAA GAAGCATTGGGGATCAAGAA 
FLG AAGGAACTTCTGGAAAAGGAATTTC TTGTGGTCTATATCCAAGTGATCCAT 
IVL TCCTCCAGTCAATACCCATCAG CAGCAGTCATGTGCTTTTCCT 
CLDN-1 GCGCGATATTTCTTCTTGCAGG TTCGTACCTGGCATTGACTGG 
OCLN TGCATGTTCGACCAATGC AAGCCACTTCCTCCATAAGG 
 
5.3.7 WESTERN BLOT 
For Western blot analysis of filaggrin, involucrin, claudin 1 and occludin the epidermis 
of skin models was shock frozen in liquid nitrogen and milled using a CryoMill (Retsch 
GmbH, Haan, Germany). The milled epidermis was then lysed in RIPA buffer 
containing protease inhibitors (New England Biolabs, Frankfurt/Main, Germany), 
centrifuged for 30 min at 14,000 × g and the supernatant was subsequently stored at -
80°C until use. The protein amount was quantified by a BCA protein assay (Thermo 
Scientific, Waltham, USA). 30 µg of each protein sample was incubated at 95°C in 
standard SDS-PAGE buffer and separated via 10% SDS polyacrylamide gel 
electrophoresis (Bio-Rad, Munich, Germany). Gels were blotted onto Immobilon P 
nitrocellulose membranes (Carl Roth, Karlsruhe, Germany) via Trans-Blot® Turbo™ 
Transfer System (Bio-Rad, Munich, Germany). After blocking with 5% non-fat dry milk 
in tris-buffered saline -Tween 20 (0.1%) for 1h, the membranes were incubated with 
primary antibodies (anti-filaggrin antibody ab81468, anti-involucrin ab53112, Abcam, 
Cambridge, UK, CLDN1 monoclonal antibody (clone 1C5-D9), OCLN monoclonal 
antibody (clone 1G7), Abnova, Taipeh, Taiwan) overnight. Subsequently, the 
membranes were washed and incubated with anti-rabbit or anti-mouse horseradish-
peroxidase-conjugated secondary antibody (Cell Signaling, Frankfurt/Main, Germany) 
at room temperature for 1h. All blots were developed with SignalFire™ ECL reagent 
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(Cell Signaling, Frankfurt/Main, Germany) and visualized by a PXi/PXi Touch gel 
imaging system (Syngene, Cambridge, UK). Protein expression was semi-quantified 
by densitometry and normalized to β-actin levels using ImageJ version 1.6 (National 
Institutes of Health, Bethesda, USA). 
 
5.3.8 SKIN PERMEABILITY TESTING 
The permeability of the skin models was evaluated according to validated test 
procedures [8]. Briefly, stock solutions of testosterone (40 µg/ml, 2% [v/v] Igepal® CA-
630) and caffeine (1 mg/ml) were spiked with an appropriate amount of the 
radiolabeled compound to achieve a total radioactivity of 2 µCi/ml. Permeation studies 
were performed at day 7 of tissue cultivation using a Franz diffusion cell setup 
(diameter 15 mm, volume 12 ml, Permegear, Bethlehem, USA). 
 
5.3.9 STATISTICAL ANALYSIS 
The data were statistically analyzed using ANOVA and one-sample or two-sample t-
test. p ≤ 0.05 was defined as the level of significance. 
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5.4 RESULTS 
5.4.1 SET-UP AND ESTABLISHMENT OF A PERFUSED BIOREACTOR  
In a first step, a perfusion platform was constructed where standard 6-well inserts fit in 
(Fig. 5-1). To ensure a laminar and continuous flow of the cultivation medium, the 
perfusion platform was equipped with two orifices to connect with the tubing. From the 
orifices, the medium got distributed by a hemicycle deepening and was transported in 
a laminar flow by introducing parallel channels into the PTFE platform right underneath 
the cell culture insert membrane. To ensure that the amount of medium entering the 
platform is identical with the amount which leaves the platform, both orifices were 
connected to the same peristaltic pump by silicon tubing ending in the medium 
reservoir (Fig. 5-1).  
 
 
  
 
 
 
 
 
 
(1) transfer of the skin models in the cell culture inserts into the perfusion platform after 
performing the air lift at day 1 of tissue cultivation, (2) capping of the platform, (3) transfer of 
the entire setup into the incubator at 37°C, 5% CO2 and 95% humidity until day 7 of tissue 
cultivation, (4) peristaltic pump for continuous flow of the skin model differentiation medium.  
 
A B 
Figure 5-1 (A) Scheme of the perfusion bioreactor. (B) Image of the perfusion platform 
equipped with cell culture insert, lid and tubing connectors. 
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5.4.2 HISTOLOGICAL ANALYSIS 
Following establishment of the perfusion platform, different medium flow rates were 
applied, ranging from 1.25 to 10 ml/h (Fig. 2). In general, all dynamically cultivated skin 
models developed a significantly thicker stratum corneum, the keratinocytes aligned to 
the direction of medium flow and a significantly thinner but more compact dermis 
equivalent was observed (Fig. 2; Fig. 3). No significant differences in epidermal 
maturation or differentiation were overserved (Fig. 3). The viable epidermis showed 
similar dimensions for all flow rates compared to the static control model.  
 
Figure 5-2 Representative histological pictures of (A) a skin model cultivated under static 
condition, (B) in the perfusion platform with a flow rate of 1.25 ml/h, (C) flow rate of 2.5 ml/h or 
(D) flow rate 7.5 ml/h after 7 days of cultivation, SC: stratum corneum , VE: viable epidermis, 
D: dermis, 20x magnification, scale bar = 100 µm. 
  
B 
A B 
C D 
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Figure 5-3 (A) Thickness of the stratum corneum after skin model cultivation of 7 days under 
static conditions or in the perfusion platform with flow rates of 1.25 ml/h, 2.5 l/h or 7.5 ml/h; (B) 
thickness of the stratum corneum (SC, light grey), viable epidermis (VE, dark grey) and dermis 
(D, white) after skin model cultivation of 7 days under static conditions or in the perfusion 
platform with flow rates of 1.25 ml/h, 2.5 l/h or 7.5 ml/h. Mean ± SEM; n = 4; *p ≤ 0.05, **p ≤ 
0.01, ***p ≤ 0.001. 
 
5.4.3 GENE AND PROTEIN EXPRESSION OF SKIN BARRIER AND TIGHT JUNCTION 
PROTEINS FOLLOWING DYNAMIC TISSUE CULTIVATION 
Western blot analysis revealed higher expression of the intermediate and late-stage 
skin differentiation markers involucrin and filaggrin indicating improved epidermal 
differentiation as well as increased expression of the tight junction proteins occludin 
and claudin-1 in the dynamically cultivated skin models (Fig. 4). Unexpectedly, 
cultivation at 7.5 ml/h showed a trend towards reduced expression of involucrin and 
occludin (Fig. 4 B; D). On mRNA level, there was a clear trend towards reduced 
expression of filaggrin, involucrin, claudin-1 and occludin after cultivation at 7.5 ml/h 
(Fig. 5): 
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Figure 5-4 Impact of tissue cultivation in the perfusion platform on expression of (A) filaggrin, 
(B) involucrin, (C) claudin 1 and (D) occludin after 7 days of cultivation. Western blots and 
relative protein expression were semi-quantified by densitometry. Mean ± SEM, n = 4, *p ≤ 
0.05. 
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Figure 5-5 Relative mRNA expression of (A) filaggrin, (B) involucrin, (C) claudin 1 and (D) 
occludin in skin models cultivated for 7 days under static or dynamic conditions. Mean ± SEM, 
n = 4, *p ≤ 0.05. 
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5.4.4 SKIN PERMEABILITY STUDIES  
To assess the barrier function of the skin models and potential positive effects of 
dynamic culture condition, skin absorption studies using the OECD reference 
substances testosterone and caffeine were performed. The testosterone flux was 
significantly increased in the skin models cultivated in the perfusion platforms (Fig. 6A; 
Tab. 2). No difference in skin permeability between statically or dynamically cultured 
skin models was detected for the more hydrophilic test compound caffeine (Fig. 6B). 
 
Figure 5-6 Cumulative amounts (mean ± SEM, n=3) of radioactively-labeled permeated (A) 
testosterone and (B) caffeine following topical application on skin models cultivated under 
static control or dynamic (1.25, 2.5, 7.5 ml/h) conditions. 
 
Table 5-2 Apparent permeability coefficient (Papp) of radioactively-labeled testosterone and 
caffeine (mean ± SD, n=3). 
 
Papp (cm/s) Static control 1.25 ml/h 2.5 ml/h 7.5 ml/h 
testosterone 4.0±1.8x10-06 8.4±1.3x10-06 7.5±1.0x10-06 9.4±2.2x10-06 
caffeine 4.4±0.2x10-04 4.4±1.3x10-04 4.3±0.7x10-04 4.4±0.8x10-04 
5. Development of a perfusion platform for dynamic cultivation of in vitro skin models 
 
 
82 
 
5.5 DISCUSSION 
Over the past 20 years, the interest in reconstructed human skin is constantly growing 
since in vitro skin models enable the reduction and replacement of animal experiments 
and help to avoid interspecies-related differences which are major reasons for the often 
discussed low predictive power of animal models [3,29]. Although the versatility of skin 
models is widely recognized today, skin models still have clear limitations such as 
increased permeability compared to native human skin [15,30,31]. This drawback may 
result from non-physiological cell culture medium, a lack of cellular crosstalk or tissue 
complexity and/or tissue cultivation under static conditions in well-plates. 
Since the impact of shear stress and mechanical forces on tissue homeostasis and 
regeneration in vivo and in vitro is well established [17,32,33], we constructed a PTFE-
based perfusion platform enabling continuous flow of skin model differentiation 
medium underneath the skin model. Following construction of the skin models in well-
plates, they were transferred to the perfusion platform at day 1 of tissue cultivation and 
were further cultivated under dynamic conditions for 7 days. At first, the impact of the 
flow rate on skin model differentiation and maturation was investigated. Clear 
detrimental effects on epidermal differentiation resulted from the highest flow rate of 
10 ml/h which was therefore excluded from further studies (data not shown). Slower 
flow velocities between 1.25 ml/h and 7.5 ml/h resulted in a significant thickening of 
the stratum corneum. This effects was comparable to previously published data, where 
the maintenance of the EpiDermFT skin model in a dynamic set-up led to a more 
pronounced stratum corneum compared to the static control [24]. Additionally, higher 
compaction of the dermis equivalent was observed likely due to detachment of collagen 
gel as a result of the media flux. 
Moreover, we observed significantly increased expression of the important skin barrier 
protein and differentiation marker filaggrin and a clear trend for increased involucrin 
expression following dynamic tissue cultivation (Fig. 4). Filaggrin is an important 
structural protein which contributes to the integrity of the epidermal barrier and the 
alignment of keratin bundles [34,35] and is disturbed in common skin diseases such 
as atopic dermatitis [36]. The intermediate-stage differentiation marker involucrin is 
part of the cornified envelope and reinforces the skin barrier [37]. Interestingly, a trend 
5. Development of a perfusion platform for dynamic cultivation of in vitro skin models 
 
 
83 
 
for reduced mRNA and protein expression was observed for cultivation at 7.5 ml/h flow 
rate which may indicate detrimental effects of high velocities on skin differentiation and 
demonstrates the importance of flow rate adjustment. In line with the epidermal barrier 
proteins, claudin-1 and occludin expression was increased after dynamic tissue 
cultivation. Again, slightly reduced expression was observed for the models cultivated 
at 7.5 ml/h. 
Based on the positive effects of the dynamic setting on skin differentiation and 
maturation, an improved barrier function of dynamically cultivated skin models was 
expected. Surprisingly, no improved skin barrier function was determined. An even 
increased permeability was determined for the lipophilic test compound testosterone 
in the dynamically cultured skin models in contrast to the static cultures. This stands in 
contrast to the significantly thicker stratum corneum as well as the increased 
expression of epidermal and tight junction proteins in the dynamically cultivated skin 
models. One can speculate about potential reasons such as detrimental effects of 
shear stress on the skin lipid organization or detrimental impact of the collagen 
detachment from the dermis equivalent, but this requires further evaluation. 
Interestingly, improved epidermal differentiation is clearly achieved (Fig. 4). Potential 
explanations, which need to be investigated further, are, for example, an increased 
release of specific growth factors as a direct result from the shear stress or improved 
nutrient supply due to introducing active mass transfer by convection as previously 
demonstrated in hollow fiber membranes used for graft cell cultivation or blood cell 
oxygenators [38–40]. Overall, the data once more highlight the complex setting of skin 
physiology and are first indications that simple perfusion of skin models might be not 
sufficient to improve the skin barrier function. 
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Reconstructed in vitro skin disease models are a sound tool to enlighten 
pathophysiological factors and correlations. They enable to study isolated aspects of 
diseases and can lay the foundation for new therapeutic strategies. Although the link 
between FLG mutations and AD is well established, the overall impact is not completely 
understood. In the first section, it was shown that the skin surface pH is maintained at 
the physiological range around pH 5.5 independently of the FLG status. The missing 
UCA and PCA, acidic degradation products of FLG, correlated with the upregulation of 
NHE-1 and sPLA2 IIA in a time dependent manner. While the higher expression of 
NHE-1 has a direct impact on the proton concentration at the skin surface, the higher 
activity of sPLA2 enzymes leads to higher amounts of FFA. Both seem to compensate 
the missing acidic degradation products of FLG, even if FLG degradation products are 
descripted as an inferior contributor to the acid mantle in the literature. The higher 
amounts of FFA lead to an impaired skin lipid formation and consequently contribute 
to the weaker barrier function found in AD patients.  
In general, the acidic skin surface pH is crucial for correct skin homeostasis. Common 
skin diseases often come with increased skin surface pH values. To further investigate 
the dependencies of the individual contributors to the acidic pH of the skin surface, an 
NHE-1 KD model and an FLG/NHE-1 KD model was established in the second section. 
The NHE-1 KD model showed a moderately but significantly elevated surface pH. This 
is in concordance with animal studies in the literature. The combined lack of FLG and 
NHE-1 did not lead to further pH increase. Consequently, it was confirmed that the 
FLG to histidine to UCA/PCA pathway is clearly less important regarding skin 
acidification. The lack of FLG is not the underlying main cause for higher pH values 
found in patients suffering from AD. Other, so far undiscovered, pathways may well be 
involved. In conclusion, it was shown that RNA interference can be used to knock down 
two genes simultaneously in skin constructs and that in vitro skin constructs are a 
suitable tool to investigate complex phenomena like pH regulation in skin. 
Besides the characterization of the previously and newly established models, this 
thesis focused on improvement and further development of in vitro skin models. 
Reconstructed full-thickness skin models are already a suitable tool for toxicity testing 
and investigations of skin physiology and pathophysiology. Nevertheless, skin models 
demonstrate clear limitations. They neither include immune cells nor vasculature and 
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they exhibit a weaker barrier function and less mechanical resistances compared to in-
vivo or ex-vivo skin. Especially, mechanical resistance and barrier function are strongly 
related to the growing conditions of in vitro skin models. The lack of mechanical forces 
and shear stress during cultivation have a distinct impact on tissue formation. To 
overcome some of those obstacles, a perfusion platform for skin cultivation was 
developed in the third section. The dynamic platform allows for a constant laminar 
medium flow below the dermis and still growth of the skin constructs at an air-liquid 
interface. The impact of different medium flow rates was investigated regarding 
histology, expression of skin differentiation factors and tight junction proteins as well 
as skin barrier function. The skin models grown in the dynamic bioreactor exhibit a two-
fold thicker stratum corneum compared to conventionally grown control models. 
Expression of the skin differentiation markers FLG and involucrin, as well as the tight 
junction proteins claudin-1 and occludin is significantly increased in dynamical grown 
skin models. Unexpectedly, despite improved skin differentiation, the skin barrier 
function was not improved. Overall, the results highlight the complex setting of tissue 
engineering and could serve as a starting point for further improvements. 
The overall results of the thesis provided new aspects of pathophysiology mechanisms 
of AD with the help of in vitro skin models. Furthermore, it was shown that the dynamic 
growing conditions of in vitro skin models have a significant influence on skin 
differentiation and generation.  
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7.1 FILAGGRIN DEFICIENCY LEADS TO IMPAIRED LIPID PROFILE AND 
ALTERED ACIDIFICATION PATHWAYS IN A 3 D SKIN CONSTRUCT 
 
Table 7-1 Ct values for NHE-1 and sPLA2-isoforms in the skin constructs (mean ± SEM, n= 
8). 
Gene Ct-values 
NHE-1 25.07 ± 0.74 
sPLA2 IB 32.66 ± 0.40 
sPLA2 IIA 37.92 ± 0.68 
sPLA2 IIF 30.80 ± 0.65 
sPLA2 V 31.11 ± 0.50 
sPLA2 XIIA 23.89 ± 0.43 
 
 
Table 7-2 Primer sequences for PCR. 
Gene Primer sense 5’-3’ Primer antisense 5’-3 
YWHAZ AGACGGAAGGTGCTGAGAAA GAAGCATTGGGGATCAAGAA 
FLG AAGGAACTTCTGGAAAAGGAATTTC TTGTGGTCTATATCCAAGTGATCCAT 
NHE-1 AGATCCAGGCTTCTCCCGGAC CCATGTGCCTGGTACCCCTGGT 
sPLA2-IB GCAATCACCTGTAGCAGCAA GTCCAGGTTCTTGTGTGCCT 
sPLA2-IIA ACCCTCCCTCCCTACCCTAAC AATCTGCTGGATGTCTCATTCTGG 
sPLA2-IIF GACCCACACCCTCTCTCC GATGCTCTCCCTGCTTACG 
sPLA2-V CTGCCTGGTTCCTGAGAGAG CAACCCTGAGTTGGAGGAGA 
sPLA2-XIIA TAGCTGTCGGCATCTCCTTT GGCATGTGAAACAACAGTGG 
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Figure 7-1 FLG degradation products UCA (a) and PCA (b) concentrations after 14 days 
cultivation in FLG+, FLG- constructs and human samples determined using HPLC analysis. 
n=5, mean ± SEM, *p ≤ 0.05 
 
 
Figure 7-2 Time dependent expression of sPLA 1B, 2F, V and XIIA in FLG+ (grey bars) and 
FLG- (white bars). 
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The skin samples were incubated without the primary antibody to ensure that the fluorescently 
labeled secondary antibody does not stain the samples unspecifically. These controls were 
run for sPLA2 immunostaining, too. No unspecific staining was detected, respectively. 
 
Figure 7-4 FLG degradation products UCA (a) and PCA (b) concentrations after 4 and 7 days 
cultivation in FLG+ (striped bars) and FLG- constructs (blank bars) determined by HPLC 
analysis. n=2, mean ± SEM, *p ≤ 0.05 
 
 
 
Figure 7-3 Negative Control of NHE-1 immunostaining with (a) and without (b) DAPI staining 
of the nuclei.  
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Figure 7-5 Knock down efficiency in FLG- skin constructs at day 4, 7 and 14. n=4, mean ± 
SEM 
 
 
 
 
Figure 7-6 pH measurement controls. 
To ensure that our pH measurement 
method can detect pH differences in 
skin constructs when present, we 
removed the epidermis from the skin 
constructs after the pH measurement 
of the skin surface. As expected, we 
detected a neutral pH proving that the 
method we are using detects pH 
differences when present. 
 
Figure 7-7 pH measurement controls. 
To ensure that our pH measurement 
method can detect pH differences in 
skin constructs when present, we 
removed the epidermis from the skin 
constructs after the pH measurement 
of the skin surface. As expected, we 
detected a neutral pH proving that the 
method we are using detects pH 
differences when present. 
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7.1.1 SUPPLEMENTARY METHODS 
7.1.1.1 Determination of PCA and UCA Levels  
For PCA analysis, SC samples were incubated with 0.1 M KOH for 2 h at 25 °C. The 
extracts were neutralized, diluted with mobile phase and centrifuged for 10 minutes at 
10.000 rpm. Isocratic elution with 20 mM ammonium formate containing 1.5 mM 
tetrabutylammonium hydroxide at pH 7.3 and 1 % acetonitrile was performed with a 
flow-rate of 0.4 ml/min. The concentration of PCA was quantified at 210 nm [2].    
For UCA analysis, the SC samples were treated with 1 M KOH for 10 minutes. The 
supernatant was acidified, and the samples were diluted with the mobile phase. 
Isocratic elution with 20 mM potassium dihydrogen phosphate containing 5 mM 
heptanesulphonic acid at pH 3.7 and 7 % acetonitrile was performed with a flow-rate 
of 0.4 ml/min [3]. UCA concentration was measured at 270 nm. For analysis, a 5 µm 
reversed-phase end-capped C18 HPLC column (Phenomenex, Aschaffenburg, 
Germany) was used.  
 
7.1.1.2 sPLA2 activity assay 
To assess the sPLA2 activity in FLG+ and FLG- constructs, an sPLA2 activity kit (Enzo 
Life Sciences, Lause, Switzerland) was used. The assay was performed according to 
the manufacturers’ protocol (http://static.enzolifesciences.com/fileadmin/files/manual/ 
ADI-907-002_insert.pdf). A standard curve was run for each assay. R2 was at least 
0.99, respectively.  
 
7.1.1.3 Skin pH Measurements 
The pH-indicator fluorescein isothiocyanate (FITC, λex 507 nm, λem 542 nm) was 
covalently linked to aminoethylcellulose to form sensor particles (FITC-AC). The 
reference dye ruthenium(II)-tris(4,7-diphenyl-1,10-phenanthroline) was incorporated in 
oxygen-impermeable polyacrylonitrile particles (Ru(dpp)3-PAN; λex 468 nm, λem 605 
nm). For further details, we refer to our methods papers [4,5]. 
FITC-AC and Ru(dpp)3-PAN were mixed in a ratio of 3/1 (w/w) and dispersed in 
solution (15 mg particles per mL) consisting of polyurethanehydrogel (type D4; 5% w/v) 
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in ethanol/water (90/10 v/v). This mix was spread on a transparent PVdC foil (thickness 
12.5 µm) with a knife-coating device to form a 120-μm-thick film. After evaporation of 
the solvent, the sensor layer was 6-μm thick. For RGB imaging, a 460-nm LED array 
was mounted on a commercial camera and served to excite the luminescent sensor. 
Emitted light was filtered by an OG510 glass filter (Schott, Mainz, Germany) and 
collected by the RGB-chip of the camera. pH-dependent signals are stored in the green 
channel, and pH-independent reference signals are stored in the red channel of the 
RGB image [1]. The green/red ratio (R) of luminescence intensities provides a 
referenced pH signal for each pixel. Foils were calibrated, and a five-parametric 
sigmoidal fit was performed. The resulting equation was then solved for pH, thus 
enabling us to calculate pH (for every pixel) based on R. Sensor foils were 
preconditioned in Ringer´s solution for 15 min prior to use. The foils were then gently 
applied to the skin constructs and allowed to slowly adapt to tissue surfaces by 
adhesion forces. Luminescence intensity ratios R were obtained for every pixel on the 
skin construct surfaces. Means of pH-dependent luminescence intensity ratios R within 
anular regions of interest (ROI; each comprising 6,249 pixels in the center of the image) 
were then computed. From the respective mean R value, mean pH for the ROI was 
calculated. Calculations and pseudocolor image processing were done with ImageX 
software (Microsoft Corporation) and ImageJ (http://rsbweb.nih.gov/ij/). For in vitro skin 
constructs, pH measurements using the glass electrode are not possible as the 
procedure would cause serious damage the skin models and, thus, no accurate 
measurement of the surface skin pH is possible. 
The validation of the method for skin surface pH measurement is described in detail in 
the paper of Schreml et al., “2D luminescence imaging of pH in vivo” 2011 in 
Proceedings of the National Academy of Sciences of the United States of America.  
Briefly, it was demonstrated that by increasing the depth of measurement (done by 
removing the epidermis layer-by-layer by tape-stripping) the pH of the skin increases 
in deeper dermal layers. The pH data were compared to values obtained by classic 
flat-bottom glass electrode measurements without detecting significant differences. In 
general, a high precision was achieved for measuring the normal skin pH (n = 10) with 
the in vivo setting: relative standard deviation of luminescence imaging 4.32 ± 1.35 %, 
relative standard deviation of glass electrode 4.53 ± 2.04 %. A Bland–Altmann mean 
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difference plot (see: Bland JM, et al., 1986) was created for method comparison, 
showing an excellent concordance (96 % of the measurements were within the 95% 
confidence interval; Krippendorf coefficient K = 0.98). Hereby, it was proven that the 
pH sensor can be reliably used in vivo and, thus, also gives reliable results for the skin 
constructs. In general, this technique can visualize pH differences with a resolution of 
≤ 5 µm [5]. Furthermore, the method is able to provide 2D mappings of pH values, 
showing distinct spatial differences. Compared to the values obtained with the one-
spot measurement technique (the glass electrode), the ROI is defined as the whole 
wound area [5]. 
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